???global.info.a_carregar???
Identification

Personal identification

Full name
Nuno Eduardo Moura dos Santos da Costa Taveira

Citation names

  • Taveira, Nuno

Author identifiers

Ciência ID
7111-3383-A926
ORCID iD
0000-0003-0176-5585

Addresses

  • Instituto Universitário Egas Moniz. Travessa da Granja- Qta da Granja, Monte de Caparica, 2829-511, Caparica, Almada, Portugal (Professional)
  • Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa , 1649-003, Av. Prof. Gama Pinto, Lisboa, Portugal (Professional)

Websites

  • http://imed.ulisboa.pt/research/program-areas/drug-usage/hiv-evolution-epidemiology-and-prevention/) (Scholar)

Knowledge fields

  • Medical and Health Sciences

Languages

Language Speaking Reading Writing Listening Peer-review
French Beginner (A1) Advanced (C1) Beginner (A1) Beginner (A1)
English Advanced (C1) Advanced (C1) Advanced (C1) Advanced (C1)
Spanish; Castilian Beginner (A1) Advanced (C1) Beginner (A1) Beginner (A1)
Education
Degree Classification
2014
Concluded
na (Título de Agregado)
Universidade de Lisboa Faculdade de Farmácia, Portugal
"na" (THESIS/DISSERTATION)
na
1996
Concluded
PhD (Doutoramento)
Universidade de Lisboa Faculdade de Farmácia, Portugal
"Estudo dos determinantes da formação de sincícios no HIV-2" (THESIS/DISSERTATION)
Summa Cum Laude
1996
Concluded
Farmácia (Doutoramento)
Major in Especialidade: Microbiologia
Universidade de Lisboa Faculdade de Farmácia, Portugal
1996
Concluded
Farmácia (Doutoramento)
Major in Especialidade: Microbiologia
Universidade de Lisboa, Portugal
"Análise Estrutural e Funcional das Glicoproteínas do Invólucro de Isolados Primários de Vih-2: Estudo dos Determinantes da Formação de Sincicios" (THESIS/DISSERTATION)
1988/06
Concluded
Ciências Farmacêuticas (Mestrado integrado)
Universidade de Lisboa Faculdade de Farmácia, Portugal
15,4
1988
Concluded
Ciências Farmacêuticas/Análises Químico-Biológicas (Licenciatura)
Major in Não Aplicável
Universidade de Lisboa Faculdade de Farmácia, Portugal
Affiliation

Teaching in Higher Education

Category
Host institution
Employer
2014 - Current Full Professor (University Teacher) Instituto Universitário Egas Moniz, Portugal
2014 - 2019 Full Professor (University Teacher) Instituto Superior de Ciências da Saúde Egas Moniz, Portugal
2014 - 2019 Full Professor (University Teacher) Instituto Universitário Egas Moniz, Portugal
2014 - 2016 Full Professor (University Teacher) Instituto Superior de Ciências da Saúde Egas Moniz, Portugal
2013 - 2014 Associate Professor (University Teacher) Instituto Superior de Ciências da Saúde Egas Moniz, Portugal
2013 - 2014 Associate Professor (University Teacher) Instituto Superior de Ciências da Saúde Egas Moniz, Portugal
2013 - 2014 Associate Professor (University Teacher) Instituto Universitário Egas Moniz, Portugal

Positions / Appointments

Category
Host institution
Employer
2022 - Current Associate Editor, Frontiers in Cellular and Infection Microbiology Frontiers Media SA, Switzerland
Frontiers Media SA, Switzerland
2022 - Current Review Editor, Frontiers in Pharmacology Frontiers Media SA, Switzerland
Frontiers Media SA, Switzerland
2021/01/01 - Current Review Editor, Frontiers in Virology Frontiers Media SA, Switzerland
2020/01/01 - Current Section Editor, Diagnostics Multidisciplinary Digital Publishing Institute AG, Switzerland
Multidisciplinary Digital Publishing Institute AG, Switzerland

Others

Category
Host institution
Employer
2022 - Current Co-Editor of Special Issue Host-Directed Therapies for HIV and RNA Respiratory Virus Infections in Viruses Multidisciplinary Digital Publishing Institute AG, Switzerland
2021 - Current Editorial Board Member, section Molecular Microbiology of International Journal of Molecular Sciences (IJMS) Multidisciplinary Digital Publishing Institute AG, Switzerland
2019 - Current Coordinator PhD program in Biomedical Sciences Instituto Universitário Egas Moniz, Portugal
Egas Moniz Cooperativa de Ensino Superior CRL, Portugal
2017 - Current Colaborator Universidade de Coimbra Centro de Química de Coimbra, Portugal
2016 - Current colaborator Centro de Investigação Interdisciplinar Egas Moniz, Portugal
Instituto Universitário Egas Moniz, Portugal
2015 - Current Cofounder and curator of the web tool termed coreceptor-hiv2.geno2pheno.org (http://coreceptor-hiv2.geno2pheno.org/index.php) Max Planck Institute for Informatics, Germany
2014/01/02 - Current Associate Researcher and Head of group Universidade de Lisboa Instituto de Investigação do Medicamento, Portugal
Universidade de Lisboa Instituto de Investigação do Medicamento, Portugal
2007 - 2014 Associate Researcher Universidade de Lisboa Instituto de Investigação do Medicamento, Portugal
Universidade de Lisboa Instituto de Investigação do Medicamento, Portugal
1997 - 2013 Coordinator, Master in Pharmaceutical Sciences Instituto Universitário Egas Moniz, Portugal
1999 - 2008 Director, SIDAnet, Associação Lusófona (www.aidsportugal.com) SIDAnet, Associação Lusófona, Portugal
2005 - 2007 Consultant in Virology Genomed, diagnósticos de medicina molecular S.A., Portugal
Projects

Contract

Designation Funders
2023/01 - 2024/12 Spiro-ß-lactams as broad-spectrum host-directed drugs for RNA respiratory viruses
Genesis Program
Grant ID Number: 17863
Co-PI
Co-Principal Investigator (Co-PI)
Universidade de Lisboa Instituto de Investigação do Medicamento, Portugal
Gilead Sciences Inc
Ongoing
2018/05 - 2024/05 Neonatal HIV early infant diagnosis (EID) versus standard of care EID - Impact on inFant hEalth (LIFE): a feasibility study of point-of care testing at birth versus at 6 weeks of age, on the uptake of ART and infant prophylaxis, and on rates of infant survival, morbidity and retention in care.
Researcher
Egas Moniz - Cooperativa de Ensino Superior Crl, Portugal
European and Developing Countries Clinical Trials Partnership
Ongoing
2023/01/01 - 2024/02/29 Development and evaluation of an mRNA vaccine against HIV-1 and HIV-2
Co-Principal Investigator (Co-PI)
Egas Moniz - Cooperativa de Ensino Superior Crl, Portugal
Gilead Sciences Lda
Concluded
2018/11/30 - 2023/10/31 Epidemiology, drug resistance and pathogenesis of HIV in Cape Verde: the Cape Verde HIV Cohort
332821690
Principal investigator
Egas Moniz - Cooperativa de Ensino Superior Crl, Portugal

Instituto Nacional de Saúde Pública, Cape Verde
FCT, Portugal, and Aga Khan Development Network (AKDN) – Portugal Collaborative Research Network in Portuguese speaking countries in Africa.
Concluded
2019/01/01 - 2019/12/31 Centro de Química - Coimbra
UID/QUI/00313/2019
Investigador colaborador
Universidade de Coimbra, Portugal

Universidade de Coimbra Centro de Química de Coimbra, Portugal
Fundação para a Ciência e a Tecnologia
Concluded
2019/01/01 - 2019/12/31 Centro de investigação interdisciplinar Egas Moniz
UID/BIM/04585/2019
Investigador Colaborador
Egas Moniz - Cooperativa de Ensino Superior Crl, Portugal

Instituto Universitário Egas Moniz Centro de Investigação Interdisciplinar Egas Moniz, Portugal
Fundação para a Ciência e a Tecnologia
Concluded
2019/01/01 - 2019/12/31 Instituto de Investigação do Medicamento
UID/DTP/04138/2019
Researcher
Universidade de Lisboa Faculdade de Farmácia, Portugal

Universidade de Lisboa Instituto de Investigação do Medicamento, Portugal
Fundação para a Ciência e a Tecnologia
Concluded
2015 - 2018 Gene therapies for HIV cure using RNA replicons targeting HIV entry and latency
Co-Principal Investigator (Co-PI)
Universidade de Lisboa Instituto de Investigação do Medicamento, Portugal

Egas Moniz - Cooperativa de Ensino Superior Crl, Portugal
Bristol Meyers Squibb Lawrenceville Route 206
Concluded
2014/04 - 2016/04 Development and pre-clinical evaluation of a new microbicide gel for the prevention of HIV-1 and HIV-2 infection
Principal investigator
Universidade de Lisboa Instituto de Investigação do Medicamento, Portugal

Egas Moniz - Cooperativa de Ensino Superior Crl, Portugal
Fundação para a Ciência e a Tecnologia
Concluded
2012/03 - 2015/09 Molecular epidemiology, drug resistance and pathogenesis of HIV and TB in Angola: the Angolan PErinatal HIV Cohort (APEHC)
Principal investigator
Egas Moniz Cooperativa de Ensino Superior CRL, Portugal
Fundação para a Ciência e a Tecnologia, I.P.
Concluded
2012/06/01 - 2015/05/31 Development of a new Nab based strategy to produce a universal HIV vaccine.
VIH/SAU/0008/2011
Co-Principal Investigator (Co-PI)
Egas Moniz - Cooperativa de Ensino Superior Crl, Portugal

Universidade de Lisboa Faculdade de Farmácia, Portugal

Instituto Universitário Egas Moniz, Portugal
Ministério da Saúde

Fundação para a Ciência e a Tecnologia
Concluded
2010/12 - 2014/09 Development and pre-clinical evaluation of a new HIV-1 vaccine concept
Principal investigator
Egas Moniz Cooperativa de Ensino Superior CRL, Portugal
Fundação para a Ciência e a Tecnologia, I.P.
Concluded
2010 - 2014 Collaborative HIV and Anti-HIV Drug Resistance Network - CHAIN
Grant agreement ID: 223131
Researcher
Universidade de Lisboa Faculdade de Farmácia, Portugal
European Union's Research and Innovation
Concluded
2011/01/01 - 2012/12/31 Projecto Estratégico - UI 775 - 2011-2012
PEst-OE/SAU/UI0775/2011
Universidade de Lisboa Faculdade de Farmácia, Portugal
Fundação para a Ciência e a Tecnologia
Concluded
2007/06/01 - 2010/11/30 Susceptibility of non-subtype B HIV-1 and HIV-2 isolates to entry inhibitors: identification and characterization of new pathways of resistance.
PTDC/SAU-FCF/67673/2006
Principal investigator
Universidade de Lisboa Faculdade de Farmácia, Portugal
Fundação para a Ciência e a Tecnologia
Concluded
2004/01/03 - 2007/12/31 Neutralization profiles of sera from human immunodeficiency virus type 2 (HIV-2)-infected individuals: relationship to HIV-2 viral load and to the genetic and phenotypic diversity of virus quasiespecies
POCTI/ESP/48045/2002
Principal investigator
Universidade de Lisboa Faculdade de Farmácia, Portugal
Fundação para a Ciência e a Tecnologia
Concluded
2004/01/01 - 2007/12/31 Study of genetic diversity and antiretroviral susceptibility of HIV-1 in Maputo, Mozambique
PSIDA/ESP/49699/2003
Principal investigator
Universidade de Lisboa Faculdade de Farmácia, Portugal
Fundação para a Ciência e a Tecnologia, I.P.
Concluded
2003 - 2007 Modulation of the immunogenic and antigenic properties of the HIV envelope V3 region by sialylation
POCTI/FCB/47407/2002
Co-Principal Investigator (Co-PI)
Instituto Superior de Ciências da Saúde Egas Moniz, Portugal
Fundação para a Ciência e a Tecnologia
Concluded
1998 - 2003 Molecular epidemiology of HIV infection in Portugal
CR3751
Principal investigator
Universidade de Lisboa Faculdade de Farmácia, Portugal
Direcção-Geral da Saúde
Concluded
1998 - 2003 Production and characterization of murine monoclonal antibodies against the envelope glycoproteins of HIV-2
CR4626
Principal investigator
Universidade de Lisboa Faculdade de Farmácia, Portugal
Direcção-Geral da Saúde
Concluded
1998 - 2002 Impact of plasma and cellular viral load in HIV-2 infection
CR3753
Principal investigator
Universidade de Lisboa Faculdade de Farmácia, Portugal
Direcção-Geral da Saúde
Concluded
1997 - 2000 Development of new immunoassays for the serologic diagnosis of HIV infection.
??????
Researcher
Universidade de Lisboa Faculdade de Farmácia, Portugal
Ministério da Economia
Concluded
Outputs

Publications

Book
  1. José Brito; Nuno Taveira; Ana I. Fernandes. The 6th International Congress of CiiEM-Immediate and Future Challenges to Foster One Health. MDPI. 2023.
    10.3390/books978-3-0365-9175-9
Book chapter
  1. Perrine Saiz ; Taveira, Nuno; Ricardo Castro Alves. "Probiotics in oral health and disease: a systematic review". In New Techniques, Materials and Technologies in Dentistry, edited by Ricardo Castro Alves; José João Mendes; Ana Cristina Mano Azul, 44-61. MDPI, 2024.
    Published • 10.3390/books978-3-7258-0098-8
  2. Brito, José; Taveira, Nuno; Ana Isabel Fernandes; José Brito; Nuno Taveira; Ana I. Fernandes. "Preface of the 6th Congress of the Egas Moniz Centre for Interdisciplinary Research-Immediate and Future Challenges to Foster One Health.". In The 6th International Congress of CiiEM—Immediate and Future Challenges to Foster One Health, 1-3. MDPI, 2023.
    Published • 10.3390/msf2023022022
  3. Inês Moranguinho; Borrego, Pedro; João Lavrado; Moreira, Rui; Taveira, Nuno. Corresponding author: Taveira, Nuno. "New Compound Combining an Integrase-Targeting Aptamer and a Small Interfering RNA Targeting the Trans-Activation Response/Poly A Region of HIV-1 Potently Suppresses HIV-1 Replication". In The 6th International Congress of CiiEM—Immediate and Future Challenges to Foster One Health, edited by José Brito; Nuno Taveira; Ana Isabel Fernandes, 55-61. MDPI, 2023.
    Published
  4. Taveira, Nuno; Francisco Martin; Inês Moranguinho. "O agente". In Manual sobre SIDA, edited by Francisco Antunes; Fernando Maltez, 1-9. Portugal: Permanyer Portugal, 2021.
    Published
  5. Taveira, Nuno; Borrego, Pedro; Gomes, Perpétua. "Agentes Antivirais". In Microbiologia Médica - Volume II, 500-511. Portugal: Lidel, 2014.
    Published
  6. Taveira, Nuno; Borrego, Pedro; Bártolo, Inês. "Biologia molecular do VIH". In Manual de VIH/SIDA, 31-52. Portugal: Pernmayer Portugal, 2011.
    Published
Conference abstract
  1. Américo J. S. Alves; Bártolo, Inês; Taveira, Nuno; Teresa M. V. D. Pinho e Melo. "New Chiral Spiro-¿-Lactams via [3 + 2] Annulation of Allenoates with 6-Alkylidenepenicillanates: Synthesis and Anti-HIV Activity, Chem. Proc. 2022, 11, 18-19.". Paper presented in 14th Edition of the Nacional Organic Chemistry Meeting and 7th Edition of the Nacional Therapeutic Chemistry Meeting., 2022.
    Published
  2. Américo J. S. Alves; Bártolo, Inês; Nuno G. Alves; Taveira, Nuno; Teresa M. V. D. Pinho e Melo; Alves, Américo; Alves, Américo J. S.; et al. "Novel Chiral Spiro-ß-Lactams from Alkylidenepenicillanates via Cycloaddition Reactions: Synthesis and Anti-HIV Activity ¿ Américo J. S. Alves oral communication.". Paper presented in International Symposium on Synthesis and Catalysis 2021 (ISySyCat2021), University of Evora (August 31st to September 3rd 2021)., Évora, 2021.
    Published
  3. Martins, Andreia; Maia, Filipa; Martin, Francisco; Rocha, Cheila; Valadas, Emília; Antunes, Francisco; Borrego, Pedro; Taveira, Nuno. "Protease diversity and resistance to protease inhibitors of viruses archived in peripheral blood mononuclear cells of HIV-2 infected patients". Paper presented in Abstract Book 12th European Workshop on HIV & Hepatitis - Treatment Strategies & Antiviral Drug Resistance. Reviews in Antiviral Therapy & Infectious Diseases, Barcelona, 2014.
    Published
  4. Marcelino, Rute; Gomes, Perpétua; Taveira, Nuno; Maria Helena Lourenço; Antunes F. "A Competitive RT-PCR Method For The Quantification Of HIV-2 Viral Load in Plasma". Paper presented in 12th World AIDS Conference, Geneva, 1998.
    Published
Conference paper
  1. Inês Moranguinho; Pedro Borrego; João Lavrado; Rui Moreira; Nuno Taveira. "New Compound Combining an Integrase-Targeting Aptamer and a Small Interfering RNA Targeting the Trans-Activation Response/Poly A Region of HIV-1 Potently Suppresses HIV-1 Replication". Paper presented in 6th Congress of the Egas Moniz Centre for Interdisciplinary Research—Immediate and Future Challenges to Foster One Health., Almada, 2023.
    Published • 10.3390/msf2023022023
  2. Taveira, Nuno. "Determinants of HIV-2 receptor use and cell tropism lie in the V3 region of the envelope glycoprotein". Paper presented in The Biochemistry Global Summit Lisbon, Lisbon, 2023.
    Published
  3. LIFE Consortium. "Birth point-of-care test & treat reduces early mortality among HIV-infected infants". Paper presented in 30th Conference on Retroviruses and Opportunistic Infections (CROI 2023), Seattle, 2023.
    Published
  4. The LIFE Consortium. "Maternal point-of-care viral load at delivery impacts infant ARV prophylaxis regimen". Paper presented in 30th Conference on Retroviruses and Opportunistic Infections (CROI2023), 2023.
    Published
  5. Perdigão, João; Silva, Carla; Diniz, Jaciara; Pereira, Catarina; Machado, Diana; Ramos, Jorge; Silva, Hugo; et al. "Mycobacterium tuberculosis genetic diversity and drug resistance across Portuguese-speaking countries and CPLP-TB: a novel framework and surveillance tool for the Lusophone community". 2019.
  6. Pineda-Peña, Andrea-Clemencia; Varanda, Jorge; Theys, Kristof; Bártolo, Inês; Leitner, Thomas; Taveira, Nuno; Vandamme, Anne-Mieke; Abecasis, Ana B.. "The contribution of Angola to the early spread of the HIV-1 epidemic". 2015.
  7. Perdigão, João; Clemente, Sofia; Ramos, Jorge; Masakidi, Pedro; Machado, Diana; Silva, Carla; Couto, Isabel; et al. "Drug resistance and genetic diversity of Mycobacterium tuberculosis in Luanda, Angola: a molecular epidemiological perspective". 2015.
  8. Borrego, Pedro; Barroso, Helena; Taveira, Nuno. "Mecanismo molecular de entrada do VIH nas células e sua inibição farmacológica". Paper presented in 8th HIV-AIDS Virtual Congress, 2008.
    Published
Conference poster
  1. Gonçalves, P; Rocha, C; Correia, V; Santos, LA; Rebelo-de-Andrade, Helena; Bártolo, Inês; Alves, NG; et al. "Novel spiro-ß-lactams as promising broad-spectrum, host-directed drugs for the treatment of respiratory RNA virus infections.". Paper presented in 14th iMed.Ulisboa Postgraduate Students Meeting., 2023.
  2. Tanajura, LS; Alves, NG; Alves, AJS; Bártolo, Inês; Taveira, Nuno; Pinho, Melo TMVD. "Novel Spiro-ß-Lactams as Broad-Spectrum Antivirals.". Paper presented in Relatório da disciplina rotação laboratorial. Coimbra Chemistry Center. Universidade de Coimbra, Coimbra, Portugal;, 2023.
  3. Bártolo, Inês; Moranguinho, Inês; Gonçalves, Paloma; Martin, Francisco; Borrego, Pedro; Alves, AJS; Alves, NG; et al. "Spiro-ß-lactam BSS-730A presents potent activity against RNA respiratory viruses and HIV". Paper presented in ASM Microbe, 2022.
  4. Américo J. S. Alves; Bártolo, Inês; Taveira, Nuno; Teresa M. V. D. Pinho e Melo. "Synthesis and Anti-HIV Evaluation of New Chiral Spiro-ß-Lactams". Paper presented in Coimbra Chemistry Centre Day 2021 (CQCday2021), University of Coimbra, 2021.
  5. Marcelino, Rute; Ezeonwumelu, Ifeanyi Jude; Janeiro, André; Mimoso, Paula; Matos, Sónia; Briz, Verónica; Pimentel, Victor; et al. "Epidemiological History of Hepatitis B Virus in Portugal and the Portuguese Role in Its Spreading Across the World". Paper presented in International AIDS Society Conference (IAS), 2021.
  6. Guerreiro Alves, Nuno; Alves, Américo; Bártolo, Inês; Simões, Carlos J.V.; Prudêncio, Miguel; Taveira, Nuno; Pinho e Melo, Teresa M.V.D.. "A novel spiro-b-lactam with potent anti-HIV and anti-plasmodial activity". Paper presented in 13th National Organic Chemistry Meeting - 6th National Medicinal Chemistry Meeting, 2020.
  7. Perdigão, João; Silva, Carla; Diniz, Jaciara; Pereira, Catarina; Machado, Diana; Ramos, Jorge; Silva, Hugo; et al. "CPLP-TB: a novel framework and surveillance tool for tracing Mycobacterium tuberculosis strains across Lusophone countries.". Paper presented in 1º Simpósio de Investigação em Tuberculose e Micobactérias Não Tuberculosas em Portugal., 2018.
  8. Ferreira, Avelino; Nunes, Rute; Bartolo, Ines; Taveira, Nuno; Sarmento, Bruno; das Neves, Jose. "The Potential of Saquinavir-loaded Nanoparticles for Rectal Microbicide Development". Paper presented in HIV research for Prevention, 2018.
  9. Calado, Rita; Duarte, Joana; Borrego, Pedro; MARCELINO, JOSÉ MARIA; Wilton, Joana; Bártolo, Inês; Martin, Francisco; et al. "A prime-boost immunization strategy with Vaccinia virus expressing novel HIV-1 gp120 glycoproteins from non-B subtypes induces tier 2 cross-clade neutralizing antibodies in mice". Paper presented in 9th iMed.ULisboa Postgraduate Students¿ Meeting, 2017.
  10. Calado, Rita; Duarte, Joana; Borrego, Pedro; MARCELINO, JOSÉ MARIA; Wilton, Joana; Bártolo, Inês; Martin, Francisco; et al. "Induction of tier 2 cross-clade neutralizing antibodies in mice by a prime- boost immunization strategy with Vaccinia virus expressing novel HIV-1 gp120 glycoproteins from non-B subtypes". Paper presented in redeSAÚDE 4th Annual Conference, ULisboa Innovation Week, 2017.
  11. Figueiredo, Inês; Calado, Rita; Martin, Francisco; Borrego, Pedro; Fernando Cardoso; Taveira, Nuno; Barroso, Helena. "Antibody response to an HIV-1/HIV-2 chimeric envelope glycoprotein in mice". Paper presented in Keystone Symposia - HIV Vaccines, 2017.
  12. Diniz, Ana Rita; Borrego, Pedro; Taveira, Nuno. "Analysis of the in vitro susceptibility of primary isolates of HIV-2 from Portugal to dolutegravir". Paper presented in Ciência 2016 ¿ Encontro com a Ciência e Tecnologia em Portugal, 2016.
  13. Calado, Rita; Duarte, Joana; Borrego, Pedro; MARCELINO, JOSÉ MARIA; Wilton, Joana; Bártolo, Inês; Clemente, Sofia; et al. "A novel prime-boost immunization strategy with Vaccinia virus expressing gp120t-AG elicit a neutralizing response in mice against autologous and heterologous tier 2 virus". Paper presented in Ciência 2016 ¿ Encontro com a Ciência e Tecnologia em Portugal,, 2016.
  14. Döring, Matthias; Borrego, Pedro; Bunch, Joachim; Friedrich, Georg; Camacho, Ricardo Jorge; Eberle, Josef; Kaiser, Rolf; et al. "geno2pheno[coreceptor-hiv2] ¿ a computational tool for the prediction of HIV-2 coreceptor usage". Paper presented in 14th European Meeting on HIV & Hepatitis 2016, 2016.
  15. Perdigão, João; Clemente, Sofia; Ramos, Jorge; Masakidi, Pedro; Machado, Diana; Silva, Carla; Couto, Isabel; et al. "First Insights on the Drug resistance and Genetic Diversity of Mycobacterium tuberculosis in Luanda, Angola". Paper presented in 26th ECCMID, 2016.
  16. Bártolo, Inês; Diniz, Ana Rita; Borrego, Pedro; Taveira, Nuno. "Pre-clinicalevaluationofanewvaginalmicrobicidegel for prevention of HIV infection". Paper presented in Keystone Symposia - HIV Vaccines, 2016.
  17. Nunes, Rute; Bártolo, Inês; Taveira, Nuno; das Neves, José; Sarmento, Bruno. "Efavirenz-loaded PLGA nanoparticles as potential rectal microbicides". Paper presented in 24th International Conference on Bioencapsulation, 2016.
  18. Ana I. Matos; Peres, Carina; Ventura, Ana Ester; Viana, Ana S. or Viana, Ana; Borrego, Pedro; Gois, Pedro; Silva, Liana C; Taveira, Nuno; Helena F Florindo. "Development of PLGA-based nanocarriers for Human Immunodeficiency Virus Type 1 vaccine delivery.". Paper presented in Molecular and Supramolecular Carriers for Imaging and Therapy Conference, FP7-PEOPLE-2012-ITN - Marie-Curie Action: "Initial Training Networks", 2015.
  19. Diniz, Ana Rita; Borrego, Pedro; Bártolo, Inês; Taveira, Nuno. "Inhibition of HIV cell-to-cell fusion by antiretroviral drugs and neutralizing antibodies". Paper presented in 7th iMed.ULisboa Postgraduate Students¿ Meeting, 2015.
  20. Diniz, Ana Rita; Briz, Verónica; Borrego, Pedro; Palladino, Claudia; Rodés, B; de la Mata, FJ; Gómez, R; Muñoz-Fernández, Maria Angel; Taveira, Nuno. "Entry Inhibitors and Carbosilane Dendrimers are Potent Inhibitors of Cell-Associated HIV-2 Infection". Paper presented in Keystone Symposia - HIV Vaccines, 2015.
  21. Calado, Rita; Duarte, Joana; Diniz, Ana Rita; Borrego, Pedro; MARCELINO, JOSÉ MARIA; Wilton, Joana; Bártolo, Inês; Clemente, Sofia; Taveira, Nuno. "Envelope C2-V3-C3-specific antibodies correlate with neutralization activity in plasma from HIV- 1 infected patients from Angola". Paper presented in Keystone Symposia - HIV Vaccines, 2015.
  22. Catarina Cunha-Santos, A; Figueira, TN; Oliveira, S; Borrego, Pedro; Couto, A; Cantante, C; Santos-Costa, Q.; et al. "Engineering synthetic domain antibodies with broad and potent HIV-1 neutralization, by direct binding to gp41 viral glycoprotein". Paper presented in 6th iMed.ULisboa Postgraduate Students¿ Meeting, 2014.
  23. Martins, Andreia; Cavaco-Silva, Joana; Borrego, Pedro; Camacho, Ricardo; Taveira, Nuno. "Phenotypic analysis of drug resistance pathways to protease inhibitors in HIV-2 infection". Paper presented in 6th iMed.ULisboa Postgraduate Students¿ Meeting, 2014.
  24. Briz, Verónica; Borrego, Pedro; Palladino, Claudia; Diezniz, AR; Rodéz, B; de la Mata, FJ; Gómez, R; Taveira, Nuno; Muñoz-Fernández, Maria Angel. "Carbosilane dendrimers as topical microbicides to prevent HIV-2 infection". Paper presented in 8th International Dendrimer Symposium, 2013.
  25. Rocha, Cheila; MARCELINO, JOSÉ MARIA; Borrego, Pedro; Calado, Rita; Tendeiro, Rita; Foxall, Russel B; Valadas, Emília; Ana Espada de Sousa; Taveira, Nuno. "Potent and broadly neutralizing antibodies are produced in chronic HIV-2 patients despite evidence of marked memory B cell depletion". Paper presented in Keystone Symposia ¿ HIV Vaccines, 2013.
  26. Rocha, Cheila; Borrego, Pedro; Calado, Rita; Barroso, Helena; Taveira, Nuno. "X4 primary isolates of HIV-2 are less susceptible to plasma antibody neutralization than R5 isolates". Paper presented in Keystone Symposia ¿ HIV Vaccines, 2013.
  27. Rocha, Cheila; Borrego, Pedro; Skar, Helena; MARCELINO, JOSÉ MARIA; Bártolo, Inês; Leitner, Thomas; Barroso, Helena; Taveira, Nuno. "Evolution of the autologous neutralizing antibody response in early HIV-2 infection". Paper presented in Keystone Symposia ¿ HIV Vaccines, 2012.
  28. Borrego, Pedro; Calado, Rita; MARCELINO, JOSÉ MARIA; Rocha, Cheila; Barroso, Helena; Taveira, Nuno. "Susceptibility of HIV-2 primary isolates to fusion and entry inhibitors". Paper presented in Keystone Symposia - Protection from HIV: Targeted Intervention Strategies (X8), 2011.
  29. Borrego, Pedro; Calado, Rita; MARCELINO, JOSÉ MARIA; Bártolo, Inês; Cavaco-Silva, Patrícia; Quintas, Alexandre; Barroso, Helena; Taveira, Nuno. "Design and evaluation of a new HIV-1 and HIV-2 fusion inhibitor peptide". Paper presented in Keystone Symposia - Protection from HIV: Targeted Intervention Strategies (X8), 2011.
  30. Taveira, Nuno; Borrego, Pedro; novo, carlos; Barroso, Helena; MARCELINO, JOSÉ MARIA. "Potent and broad spectrum anti-HIV-2 neutralizing antibodies induced by C2V3C3-directed vaccination". Paper presented in Keystone Symposia - HIV Vaccines, 2010.
  31. Borrego, Pedro; MARCELINO, JOSÉ MARIA; Rocha, Cheila; Doroana, Manuela; Maltez, Fernando; Barroso, Helena; Taveira, Nuno. "Evolutionary features underlying the differences in HIV-1 and HIV-2 clinical outcome". Paper presented in 15th International BioInformatics Workshop on Virus Evolution and Molecular Epidemiology, 2009.
  32. Skar, Helena; Borrego, Pedro; MARCELINO, JOSÉ MARIA; Wilbe, Karine; Alaeus, Annette; Rocha, Cheila; Barroso, Helena; et al. "The rate of HIV-2 evolution". Paper presented in 15th International HIV Dynamics & Evolution, 2008.
  33. Borrego, Pedro; MARCELINO, JOSÉ MARIA; Rocha, Cheila; Doroana, Manuela; Maltez, Fernando; Barroso, Helena; Taveira, Nuno. "Interplay between the immune response to the envelope glycoproteins and viral evolution in chronic HIV-2 infection". Paper presented in Keystone Symposia HIV Vaccines: Progress and Prospects, 2008.
  34. Borrego, Pedro; MARCELINO, JOSÉ MARIA; Rocha, Cheila; Doroana, Manuela; Maltez, Fernando; Barroso, Helena; Taveira, Nuno. "Intrapatient molecular evolution of the env gene in HIV-2 infection". Paper presented in 13th International BioInformatics Workshop on Virus Evolution and Molecular Epidemiology, 2007.
Journal article
  1. da Veiga Leal, Silvânia; de Pina Araújo, Isabel Inês; Pimentel, Victor; Parreira, Ricardo; Gonçalves, Paloma; Pingarilho, Marta; Taveira, Nuno; Barroso Abecasis, Ana. "Epidemiological, behavioural and molecular profile of individuals newly diagnosed with HIV-1 in Cabo Verde". (2024): https://doi.org/10.25761/anaisihmt.455.
    https://doi.org/10.25761/anaisihmt.455
  2. Cortesi, Paolo Angelo; Fornari, Carla; Conti, Sara; Antonazzo, Ippazio Cosimo; Ferrara, Pietro; Ahmed, Ayman; Andrei, Catalina Liliana; et al. "Hepatitis B and C in Europe: an update from the Global Burden of Disease Study 2019". The Lancet Public Health 8 9 (2023): e701-e716. http://dx.doi.org/10.1016/s2468-2667(23)00149-4.
    Open access • Published • 10.1016/s2468-2667(23)00149-4
  3. Nuno Taveira. "Antivirals and Vaccines". International Journal of Molecular Sciences (2023): https://doi.org/10.3390/ijms241210315.
    10.3390/ijms241210315
  4. Nuno Taveira; Inês Figueiredo; Rita Calado; Francisco Martin; Inês Bártolo; José M. Marcelino; Pedro Borrego; et al. "An HIV-1/HIV-2 Chimeric Envelope Glycoprotein Generates Binding and Neutralising Antibodies against HIV-1 and HIV-2 Isolates". International Journal of Molecular Sciences (2023): https://doi.org/10.3390/ijms24109077.
    10.3390/ijms24109077
  5. Inês Moranguinho; Nuno Taveira; Inês Bártolo. "Antiretroviral Treatment of HIV-2 Infection: Available Drugs, Resistance Pathways, and Promising New Compounds". International Journal of Molecular Sciences (2023): https://doi.org/10.3390/ijms24065905.
    10.3390/ijms24065905
  6. Assunção, Mariana Anselmo; Botelho, João; Machado, Vanessa; Proença, Luís; Matos, António P. A.; Mendes, José João; Bessa, Lucinda J.; Taveira, Nuno; Santos, Alexandre. "Dental Implant Surface Decontamination and Surface Change of an Electrolytic Method versus Mechanical Approaches: A Pilot In Vitro Study". Journal of Clinical Medicine 12 4 (2023): 1703. http://dx.doi.org/10.3390/jcm12041703.
    10.3390/jcm12041703
  7. Marcelino, Rute; Ezeonwumelu, Ifeanyi Jude; Janeiro, André; Mimoso, Paula; Matos, Sónia; Briz, Veronica; Pimentel, Victor; et al. Corresponding author: Marcelino, Rute. "Phylogeography of hepatitis B virus: The role of Portugal in the early dissemination of HBV worldwide". PLOS ONE 17 12 (2022): e0276618. http://dx.doi.org/10.1371/journal.pone.0276618.
    10.1371/journal.pone.0276618
  8. Martin, Francisco; Marcelino, José Maria; Palladino, Claudia; Bártolo, Inês; Tracana, Susana; Moranguinho, Inês; Gonçalves, Paloma; et al. "Long-Term and Low-Level Envelope C2V3 Stimulation by Highly Diverse Virus Isolates Leads to Frequent Development of Broad and Elite Antibody Neutralization in HIV-1-Infected Individuals". Microbiology Spectrum 10 6 (2022): http://dx.doi.org/10.1128/spectrum.01634-22.
    10.1128/spectrum.01634-22
  9. Haeuser, Emily; Serfes, Audrey L.; Cork, Michael A.; Yang, Mingyou; Abbastabar, Hedayat; Abhilash, E. S.; Adabi, Maryam; et al. "Mapping age- and sex-specific HIV prevalence in adults in sub-Saharan Africa, 2000-2018". BMC Medicine 20 1 (2022): http://dx.doi.org/10.1186/s12916-022-02639-z.
    10.1186/s12916-022-02639-z
  10. Alves, Américo J. S.; Alves, Nuno G.; Bártolo, Inês; Fontinha, Diana; Caetano, Soraia; Prudêncio, Miguel; Taveira, Nuno; Pinho e Melo, Teresa M. V. D.. "Unveiling a family of spiro-ß-lactams with anti-HIV and antiplasmodial activity via phosphine-catalyzed [3+2] annulation of 6-alkylidene-penicillanates and allenoates". Frontiers in Chemistry 10 (2022): http://dx.doi.org/10.3389/fchem.2022.1017250.
    10.3389/fchem.2022.1017250
  11. Yann Le Gal; Agathe Filatre-Furcate; Dominique Lorcy; Olivier Jeannin; Thierry ROISNEL; Vincent Dorcet; Diana Fontinha; et al. "Broad Spectrum Functional Activity of Structurally Related Monoanionic Au(III) Bis(Dithiolene) Complexes". International Journal of Molecular Sciences (2022): https://www.mdpi.com/1422-0067/23/13/7146.
    10.3390/ijms23137146
  12. Bártolo, Inês; Moranguinho, Inês; Gonçalves, Paloma; Diniz, Ana Rita; Borrego, Pedro; Martin, Francisco; Figueiredo, Inês; et al. "High Instantaneous Inhibitory Potential of Bictegravir and the New Spiro-ß-Lactam BSS-730A for HIV-2 Isolates from RAL-Naïve and RAL-Failing Patients". International Journal of Molecular Sciences (2022): http://hdl.handle.net/10362/146337.
    https://doi.org/10.3390/ijms232214300
  13. Perrine Saïz; Nuno Taveira; Ricardo Alves. "Probiotics in Oral Health and Disease: A Systematic Review". Applied Sciences 11 17 (2021): 8070-8070. https://doi.org/10.3390/app11178070.
    10.3390/app11178070
  14. Vânia M. Moreira; Paulo Mascarenhas; Vanessa Machado; João Botelho; José João Mendes; Nuno Taveira; M. Gabriela Almeida; et al. "Diagnosis of SARS-Cov-2 Infection by RT-PCR Using Specimens Other Than Naso- and Oropharyngeal Swabs: A Systematic Review and Meta-Analysis". Diagnostics (2021): https://doi.org/10.3390/diagnostics11020363.
    10.3390/diagnostics11020363
  15. Serra, Patrícia A.; Taveira, Nuno; Guedes, Rita C.. "Computational Modulation of the V3 Region of Glycoprotein gp125 of HIV-2". International Journal of Molecular Sciences 22 4 (2021): 1948. http://dx.doi.org/10.3390/ijms22041948.
    10.3390/ijms22041948
  16. Bártolo, Inês; Santos, Bruna S.; Fontinha, Diana; Machado, Marta; Francisco, Denise; Sepodes, Bruno; Rocha, João; et al. "Spiro-ß-lactam BSS-730A Displays Potent Activity against HIV and Plasmodium". ACS Infectious Diseases 7 2 (2021): 421-434. http://dx.doi.org/10.1021/acsinfecdis.0c00768.
    10.1021/acsinfecdis.0c00768
  17. Alves, Nuno Guerreiro; Bártolo, Inês; Alves, Américo J.S.; Fontinha, Diana; Francisco, Denise; Lopes, Susana M.M.; Soares, Maria I.L.; et al. "Synthesis and structure-activity relationships of new chiral spiro-ß-lactams highly active against HIV-1 and Plasmodium". (2021): http://hdl.handle.net/10451/49470.
    10.1016/j.ejmech.2021.113439
  18. Marcelino, Rute; Gramacho, Filipa; Martin, Francisco; Brogueira, Pedro; Janeiro, Nuno; Afonso, Claudia; Badura, Robert; et al. "Antibody response against selected epitopes in the HIV-1 envelope gp41 ectodomain contributes to reduce viral burden in HIV-1 infected patients". (2021): http://hdl.handle.net/10362/130472.
    https://doi.org/10.1038/s41598-021-88274-9
  19. Jahagirdar, Deepa; Walters, Magdalene K.; Novotney, Amanda; Brewer, Edmond D.; Frank, Tahvi D.; Carter, Austin; Biehl, Molly H.; et al. "Global, regional, and national sex-specific burden and control of the HIV epidemic, 1990-2019, for 204 countries and territories: the Global Burden of Diseases Study 2019". The Lancet HIV 8 10 (2021): e633-e651. https://publons.com/wos-op/publon/50632519/.
    10.1016/s2352-3018(21)00152-1
  20. Sartorius, Benn; Van der Heide, John; Yang, Mingyou; Goosmann, Erik; Hon, Julia; Haeuser, Emily; Cork, Michael; et al. "Subnational mapping of HIV incidence and mortality among individuals aged 15-49 years in sub-Saharan Africa, 2000-18: a modelling study". The Lancet HIV 8 6 (2021): e363-e375. https://publons.com/wos-op/publon/46989574/.
    10.1016/s2352-3018(21)00051-5
  21. Cadima-Couto, Iris; Tauzin, Alexandra; Freire, João M.; Figueira, Tiago N.; Silva, Rúben D. M.; Pérez-Peinado, Clara; Cunha-Santos, Catarina; et al. "Anti-HIV-1 Activity of pepRF1, a Proteolysis-Resistant CXCR4 Antagonist Derived from Dengue Virus Capsid Protein". ACS Infectious Diseases 7 1 (2020): 6-22. http://dx.doi.org/10.1021/acsinfecdis.9b00507.
    10.1021/acsinfecdis.9b00507
  22. Local Burden of Disease Vaccine Coverage Collaborators. "Mapping routine measles vaccination in low- and middle-income countries.". Nature (2020): http://europepmc.org/abstract/med/33328634.
    10.1038/s41586-020-03043-4
  23. Vos, Theo; Lim, Stephen S; Abbafati, Cristiana; Abbas, Kaja M; Abbasi, Mohammad; Abbasifard, Mitra; Abbasi-Kangevari, Mohsen; et al. "Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019". The Lancet 396 10258 (2020): 1204-1222. http://dx.doi.org/10.1016/s0140-6736(20)30925-9.
    Open access • Published • 10.1016/s0140-6736(20)30925-9
  24. Wang, Haidong; Abbas, Kaja M; Abbasifard, Mitra; Abbasi-Kangevari, Mohsen; Abbastabar, Hedayat; Abd-Allah, Foad; Abdelalim, Ahmed; et al. "Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950–2019: a comprehensive demographic analysis for the Global Burden of Disease Study 2019". The Lancet 396 10258 (2020): 1160-1203. http://dx.doi.org/10.1016/s0140-6736(20)30977-6.
    Open access • Published • 10.1016/s0140-6736(20)30977-6
  25. Murray, Christopher J L; Aravkin, Aleksandr Y; Zheng, Peng; Abbafati, Cristiana; Abbas, Kaja M; Abbasi-Kangevari, Mohsen; Abd-Allah, Foad; et al. "Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019". The Lancet 396 10258 (2020): 1223-1249. http://dx.doi.org/10.1016/s0140-6736(20)30752-2.
    Open access • Published • 10.1016/s0140-6736(20)30752-2
  26. Palladino C; Ezeonwumelu IJ; Mate-Cano I; Borrego P; Martínez-Román P; Arca-Lafuente S; Resino S; Taveira N; Briz V. "Epidemic history and baseline resistance to NS5A-specific direct acting drugs of hepatitis C virus in Spain.". Scientific reports (2020): http://europepmc.org/abstract/med/32747734.
    10.1038/s41598-020-69692-7
  27. LBD Double Burden of Malnutrition Collaborators. "Author Correction: Mapping local patterns of childhood overweight and wasting in low- and middle-income countries between 2000 and 2017.". Nature medicine (2020): http://europepmc.org/abstract/med/32616917.
    10.1038/s41591-020-0972-7
  28. Tzou PL; Descamps D; Rhee SY; Raugi DN; Charpentier C; Taveira N; Smith RA; et al. "Expanded Spectrum of Antiretroviral-Selected Mutations in Human Immunodeficiency Virus Type 2.". The Journal of infectious diseases (2020): http://europepmc.org/abstract/med/31965175.
    10.1093/infdis/jiaa026
  29. Rita Calado; Joana Duarte; Pedro Borrego; José Maria Marcelino; Inês Bártolo; Francisco Martin; Inês Figueiredo; et al. "A Prime-Boost Immunization Strategy with Vaccinia Virus Expressing Novel gp120 Envelope Glycoprotein from a CRF02_AG Isolate Elicits Cross-Clade Tier 2 HIV-1 Neutralizing Antibodies". Vaccines (2020): https://www.mdpi.com/2076-393X/8/2/171.
    10.3390/vaccines8020171
  30. Moranguinho, Inês; Borrego, Pedro; Gonçalves, Fátima; Gomes, Perpétua; Rocha, José; Barreto, Jorge; Taveira, Nuno. "Genotypic resistance profiles of HIV-2-infected patients from Cape Verde failing first-line antiretroviral therapy". AIDS 34 3 (2020): 483-486. http://dx.doi.org/10.1097/qad.0000000000002431.
    Published • 10.1097/qad.0000000000002431
  31. Reiner, R.C.; Hay, S.I.; Wiens, K.E.; Deshpande, A.; Baumann, M.M.; Lindstedt, P.A.; Blacker, B.F.; et al. "Mapping geographical inequalities in childhood diarrhoeal morbidity and mortality in low-income and middle-income countries, 2000–17: analysis for the Global Burden of Disease Study 2017". The Lancet (2020): http://www.scopus.com/inward/record.url?eid=2-s2.0-85085028721&partnerID=MN8TOARS.
    10.1016/S0140-6736(20)30114-8
  32. Deng, X.; Achari, A.; Federman, S.; Yu, G.; Somasekar, S.; Bártolo, I.; Yagi, S.; et al. "Metagenomic sequencing with spiked primer enrichment for viral diagnostics and genomic surveillance". Nature Microbiology 5 3 (2020): 443-454. http://www.scopus.com/inward/record.url?eid=2-s2.0-85077844387&partnerID=MN8TOARS.
    10.1038/s41564-019-0637-9
  33. Kinyoki, D.K.; Ross, J.M.; Lazzar-Atwood, A.; Munro, S.B.; Schaeffer, L.E.; Abbasalizad-Farhangi, M.; Abbasi, M.; et al. "Mapping local patterns of childhood overweight and wasting in low- and middle-income countries between 2000 and 2017". Nature Medicine 26 5 (2020): 750-759. http://www.scopus.com/inward/record.url?eid=2-s2.0-85084142866&partnerID=MN8TOARS.
    10.1038/s41591-020-0807-6
  34. Adeoye, O.; Bártolo, I.; Conceição, J.; da Silva, A.B.; Duarte, N.; Francisco, A.P.; Taveira, N.; Cabral-Marques, H.. "Pyromellitic dianhydride crosslinked soluble cyclodextrin polymers: Synthesis, lopinavir release from sub-micron sized particles and anti-HIV-1 activity". International journal of pharmaceutics 583 (2020): 119356-119356. http://www.scopus.com/inward/record.url?eid=2-s2.0-85085265878&partnerID=MN8TOARS.
    10.1016/j.ijpharm.2020.119356
  35. Deng, X.; Achari, A.; Federman, S.; Yu, G.; Somasekar, S.; Bártolo, I.; Yagi, S.; et al. "Author Correction: Metagenomic sequencing with spiked primer enrichment for viral diagnostics and genomic surveillance (Nature Microbiology, (2020), 10.1038/s41564-019-0637-9)". Nature Microbiology (2020): http://www.scopus.com/inward/record.url?eid=2-s2.0-85078187440&partnerID=MN8TOARS.
    10.1038/s41564-020-0671-7
  36. Reiner, R.C.; Wiens, K.E.; Deshpande, A.; Baumann, M.M.; Lindstedt, P.A.; Blacker, B.F.; Troeger, C.E.; et al. "Department of Error: Mapping geographical inequalities in childhood diarrhoeal morbidity and mortality in low-income and middle-income countries, 2000–17: analysis for the Global Burden of Disease Study 2017 (The Lancet (2020) 395(10239) (1779–1801), (S0140673620301148), (10.1016/S0140-6736(20)30114-8))". The Lancet 395 10239 (2020): 1762-1762. http://www.scopus.com/inward/record.url?eid=2-s2.0-85085747349&partnerID=MN8TOARS.
    10.1016/S0140-6736(20)31248-4
  37. Pais, R.J.; Taveira, N.; Pais RJ; Taveira N; Ricardo Jorge Pais; Nuno Taveira. "Predicting the evolution and control of the COVID-19 pandemic in Portugal". F1000Research 9 (2020): 283-283. http://www.scopus.com/inward/record.url?eid=2-s2.0-85086677357&partnerID=MN8TOARS.
    10.12688/f1000research.23401.1
  38. Abbafati, C.; Machado, D.B.; Cislaghi, B.; Salman, O.M.; Karanikolos, M.; McKee, M.; Abbas, K.M.; et al. "Five insights from the Global Burden of Disease Study 2019". The Lancet 396 10258 (2020): 1135-1159. http://www.scopus.com/inward/record.url?eid=2-s2.0-85092708402&partnerID=MN8TOARS.
    10.1016/S0140-6736(20)31404-5
  39. Alves, Américo J. S.; Alves, Nuno G.; Caratão, Cátia C.; Esteves, Margarida I. M.; Fontinha, Diana; Bártolo, Inês; Soares, Maria I. L.; et al. "Spiro-Lactams as Novel Antimicrobial Agents". Current Topics in Medicinal Chemistry 19 (2020): http://hdl.handle.net/10316/90921.
    10.2174/1568026619666191105110049
  40. Cunha-Santos C; Perdigao PRL; Martin F; Oliveira JG; Cardoso M; Manuel A; Taveira N; Goncalves J. "Inhibition of HIV replication through siRNA carried by CXCR4-targeted chimeric nanobody.". Cellular and molecular life sciences : CMLS (2019): http://europepmc.org/abstract/med/31641784.
    10.1007/s00018-019-03334-8
  41. Burstein R; Henry NJ; Collison ML; Marczak LB; Sligar A; Watson S; Marquez N; et al. "Mapping 123 million neonatal, infant and child deaths between 2000 and 2017.". Nature (2019): http://europepmc.org/abstract/med/31619795.
    10.1038/s41586-019-1545-0
  42. GBD 2017 HIV collaborators. "Global, regional, and national incidence, prevalence, and mortality of HIV, 1980-2017, and forecasts to 2030, for 195 countries and territories: a systematic analysis for the Global Burden of Diseases, Injuries, and Risk Factors Study 2017.". The lancet. HIV (2019): http://europepmc.org/abstract/med/31439534.
    10.1016/S2352-3018(19)30196-1
  43. Pereira, Gonçalo Martins; Oliveira, Pedro; Taveira, Nuno. "Evolution of the prevalence and incidence of oral disorders in Portugal, 1990–2016: findings from the Global Burden of Disease 2016 Study". Annals of Medicine 51 sup1 (2019): 67-67. http://dx.doi.org/10.1080/07853890.2018.1561620.
    Open access • Published • 10.1080/07853890.2018.1561620
  44. López-Huertas MR; Palladino C; Garrido-Arquero M; Esteban-Cartelle B; Sánchez-Carrillo M; Martínez-Román P; Martín-Carbonero L; Ryan P; Multidisciplinary Group of viral coinfection HIV/Hepatitis (COVIHEP). "HCV-coinfection is related to an increased HIV-1 reservoir size in cART-treated HIV patients: a cross-sectional study.". Scientific reports (2019): http://europepmc.org/abstract/med/30944340.
    10.1038/s41598-019-41788-9
  45. Nunes R; Araújo F; Barreiros L; Bártolo I; Segundo MA; Taveira N; Sarmento B; das Neves J. "Correction to "Noncovalent PEG Coating of Nanoparticle Drug Carriers Improves the Local Pharmacokinetics of Rectal Anti-HIV Microbicides".". ACS applied materials & interfaces (2019): http://europepmc.org/abstract/med/30666872.
    10.1021/acsami.8b22242
  46. Bártolo, Inês; Borrego, Pedro; Gomes, Perpétua; Gonçalves, Fátima; Caixas, Umbelina; Pinto, Inês V.; Taveira, Nuno. "In vitro evaluation of novel reverse transcriptase inhibitors TAF (tenofovir alafenamide) and OBP-601 (2,3-didehydro-3-deoxy-4-ethynylthymidine) against multi-drug resistant primary isolates of HIV-2". Antiviral Research 161 (2019): 85-89. http://dx.doi.org/10.1016/j.antiviral.2018.10.018.
    Published • 10.1016/j.antiviral.2018.10.018
  47. Perdigão, J.; Silva, C.; Diniz, J.; Pereira, C.; Machado, D.; Ramos, J.; Silva, H.; et al. "Clonal expansion across the seas as seen through CPLP-TB database: A joint effort in cataloguing Mycobacterium tuberculosis genetic diversity in Portuguese-speaking countries". Infection, Genetics and Evolution 72 (2019): 44-58. http://www.scopus.com/inward/record.url?eid=2-s2.0-85045092372&partnerID=MN8TOARS.
    10.1016/j.meegid.2018.03.011
  48. Perdigão, João; Silva, Carla; Diniz, Jaciara; Pereira, Catarina; Machado, Diana; Ramos, Jorge; Silva, Hugo; et al. "CPLP-TB: a new tuberculosis transnational surveillance tool for the lusophone community". (2019): http://anaisihmt.com/index.php/ihmt/article/view/278.
    10.25761/anaisihmt.278
  49. Stanaway, J.D.; Afshin, A.; Gakidou, E.; Lim, S.S.; Abate, D.; Abate, K.H.; Abbafati, C.; et al. "Erratum: Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 (The Lancet (2018) 392(10159) (1923–1994), (S0140673618322256), (10.1016/S0140-6736(18)32225-6))". The Lancet 393 10190 (2019): e44-e44. http://www.scopus.com/inward/record.url?eid=2-s2.0-85067299595&partnerID=MN8TOARS.
    10.1016/S0140-6736(19)31429-1
  50. Amorim, António; Fernandes, Teresa; Taveira, Nuno; António Amorim; Teresa Fernandes; Nuno Taveira; Amorim A; Fernandes T; Taveira N. "Mitochondrial DNA in human identification: a review". PeerJ (2019): http://hdl.handle.net/10400.26/36762.
    10.7717/peerj.7314
  51. Serra, Patricia; Martins, Andreia; Taveira, Nuno; Guedes, Rita C.. "Structural elucidation and molecular dynamics study targeting the viral surface glycoproteins against HIV-2 infection". Annals of Medicine (2019): https://publons.com/wos-op/publon/28615119/.
    10.1080/07853890.2018.1561994
  52. Goncalves, Patricia; Marcelino, Rute; Calado, Rita; Martin, Francisco; Goncalves, Paloma; Janeiro, Nuno; Neno, Miguel; et al. "Antibody neutralization and its determinants in HIV-1 infected patients from Portugal: implications for vaccine design and efficacy". Annals of Medicine (2019): https://publons.com/wos-op/publon/31692539/.
    10.1080/07853890.2018.1561831
  53. Martin, F.; Palladino, C.; Mateus, R.; Diniz, A. R.; Calado, R.; Figueiredo, I.; Bartolo, I.; et al. "Broad and potent neutralizing antibody responses in HIV-1 infected Angolan patients: implications for vaccine design and efficacy". HIV Medicine (2019): https://publons.com/wos-op/publon/31692538/.
  54. Palladino, Claudia; Ezeonwumelu, Ifeanyi J.; Borrego, Pedro; Mate-Cano, Irene; Martínez-Román, Paula; Arca-Lafuente, Sonia; Resino, Salvador; Taveira, Nuno; Briz, Verónica. "HCV-GT1A Spatiotemporal Distribution, Edpidemic History, and NS5A Resistance in Spain". Topics in Antiviral Medicine 27 Suppl 1 (2019): 226s-227s. https://www.iasusa.org/tam/may-2019-special-issue/.
    Published
  55. GBD 2017 SDG Collaborators. "Measuring progress from 1990 to 2017 and projecting attainment to 2030 of the health-related Sustainable Development Goals for 195 countries and territories: a systematic analysis for the Global Burden of Disease Study 2017.". Lancet (London, England) (2018): http://europepmc.org/abstract/med/30496107.
    10.1016/S0140-6736(18)32281-5
  56. GBD 2017 Population and Fertility Collaborators. "Population and fertility by age and sex for 195 countries and territories, 1950-2017: a systematic analysis for the Global Burden of Disease Study 2017.". Lancet (London, England) (2018): http://europepmc.org/abstract/med/30496106.
    10.1016/S0140-6736(18)32278-5
  57. Roth, Gregory A; Abate, Degu; Abate, Kalkidan Hassen; Abay, Solomon M; Abbafati, Cristiana; Abbasi, Nooshin; Abbastabar, Hedayat; et al. "Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017". The Lancet 392 10159 (2018): 1736-1788. http://dx.doi.org/10.1016/s0140-6736(18)32203-7.
    Open access • 10.1016/s0140-6736(18)32203-7
  58. James, Spencer L; Abate, Degu; Abate, Kalkidan Hassen; Abay, Solomon M; Abbafati, Cristiana; Abbasi, Nooshin; Abbastabar, Hedayat; et al. "Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017". The Lancet 392 10159 (2018): 1789-1858. http://dx.doi.org/10.1016/s0140-6736(18)32279-7.
    Open access • Published • 10.1016/s0140-6736(18)32279-7
  59. GBD 2017 Risk Factor Collaborators. "Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.". Lancet (London, England) (2018): http://europepmc.org/abstract/med/30496105.
    10.1016/S0140-6736(18)32225-6
  60. GBD 2017 DALYs and HALE Collaborators. "Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.". Lancet (London, England) (2018): http://europepmc.org/abstract/med/30415748.
    10.1016/S0140-6736(18)32335-3
  61. GBD 2017 Mortality Collaborators. "Global, regional, and national age-sex-specific mortality and life expectancy, 1950-2017: a systematic analysis for the Global Burden of Disease Study 2017.". Lancet (London, England) (2018): http://europepmc.org/abstract/med/30496102.
    10.1016/S0140-6736(18)31891-9
  62. Nunes R; Araújo F; Barreiros L; Bártolo I; Segundo MA; Taveira N; Sarmento B; das Neves J. "Noncovalent PEG Coating of Nanoparticle Drug Carriers Improves the Local Pharmacokinetics of Rectal Anti-HIV Microbicides.". ACS applied materials & interfaces (2018): http://europepmc.org/abstract/med/30234288.
    10.1021/acsami.8b12214
  63. Ezeonwumelu, Ifeanyi; Bártolo, Inês; Martin, Francisco; Abecasis, Ana; Campos, Teresa; Romero-Severson, Ethan O.; Leitner, Thomas; Taveira, Nuno. "Accidental Father-to-Son HIV-1 Transmission During the Seroconversion Period". AIDS Research and Human Retroviruses 34 10 (2018): 857-862. http://dx.doi.org/10.1089/aid.2018.0060.
    Published • 10.1089/aid.2018.0060
  64. Palladino C; Ezeonwumelu IJ; Marcelino R; Briz V; Moranguinho I; Serejo F; Velosa JF; et al. "Epidemic history of hepatitis C virus genotypes and subtypes in Portugal.". Scientific reports (2018): http://europepmc.org/abstract/med/30116054.
    10.1038/s41598-018-30528-0
  65. Bártolo, Inês; Diniz, Ana Rita; Borrego, Pedro; Ferreira, João Pedro; Bronze, Maria Rosário; Barroso, Helena; Pinto, Rui; et al. "Correction: Evaluation of the fusion inhibitor P3 peptide as a potential microbicide to prevent HIV transmission in women". PLOS ONE 13 5 (2018): e0197015. http://dx.doi.org/10.1371/journal.pone.0197015.
    Open access • Published • 10.1371/journal.pone.0197015
  66. Amorim A; Afonso Costa A; Vieira da Silva C; Ribeiro T; Porto MJ; Taveira N; Fernandes T; et al. "A65 Mitochondrial DNA studies of Lisbon immigrants from Portuguese speaking African countries.". Virus Evolution 4 suppl_1 (2018): http://europepmc.org/abstract/PMC/PMC5905533.
    Published • 10.1093/ve/vey010.064
  67. Figueiredo, I. B.; Calado, R.; Martin, F.; Borrego, P.; Cardoso, F.; Taveira, N.; Barroso, H.. "HIV-1/HIV-2 chimeric envelope glycoprotein elicits strong antibody response in mice. Translational Research and Innovation in Human and Health Science". Annals of Medicine 50 sup1 (2018): S10-S170. http://dx.doi.org/10.1080/07853890.2018.1427445.
    Published • 10.1080/07853890.2018.1427445
  68. Amorim, Antonio; Fernandes, Teresa; Taveira, Nuno. "Mitochondrial DNA: approach of a genetic marker with population, forensic and medical-legal applications. Translational Research and Innovation in Human and Health Science". Annals of Medicine 50 sup1 (2018): S10-S170. http://dx.doi.org/10.1080/07853890.2018.1427445.
    Published • 10.1080/07853890.2018.1427445
  69. El Bcheraoui, C.; Wang, H.; Charara, R.; Khalil, I.; Moradi-Lakeh, M.; Afshin, A.; Collison, M.; et al. "Trends in HIV/AIDS morbidity and mortality in Eastern Mediterranean countries, 1990–2015: findings from the Global Burden of Disease 2015 study". International Journal of Public Health 63 (2018): 123-136. http://www.scopus.com/inward/record.url?eid=2-s2.0-85026848284&partnerID=MN8TOARS.
    10.1007/s00038-017-1023-0
  70. Fullman, N.; Yearwood, J.; Abay, S.M.; Abbafati, C.; Abd-Allah, F.; Abdela, J.; Abdelalim, A.; et al. "Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations: A systematic analysis from the Global Burden of Disease Study 2016". The Lancet 391 10136 (2018): 2236-2271. http://www.scopus.com/inward/record.url?eid=2-s2.0-85047728707&partnerID=MN8TOARS.
    10.1016/S0140-6736(18)30994-2
  71. Roth, G.A.; Abate, D.; Abate, K.H.; Abay, S.M.; Abbafati, C.; Abbasi, N.; Abbastabar, H.; et al. "Erratum: Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017 (The Lancet (2018) 392(10159) (1736–1788)(S0140673618322037)(10.1016/S0140-6736(18)32203-7))". The Lancet 392 10160 (2018): 2170-2170. http://www.scopus.com/inward/record.url?eid=2-s2.0-85057157683&partnerID=MN8TOARS.
    Published • 10.1016/S0140-6736(18)32833-2
  72. Bártolo, Inês; Diniz, Ana Rita; Borrego, Pedro; Ferreira, João Pedro; Bronze, Maria Rosário; Barroso, Helena; Pinto, Rui; et al. "Evaluation of the fusion inhibitor P3 peptide as a potential microbicide to prevent HIV transmission in women". PLoS ONE 13 4 (2018): http://hdl.handle.net/10400.26/30191.
    Published • 10.1371/journal.pone.0195744
  73. Martin, F.; Martins, A.; Maia, F.; Rocha, C.; Borrego, P.; Antunes, F.; Caldeira, L.; Valadas, E.; Taveira, N.. "Resistance mutations to protease inhibitors in proviral DNA of HIV-2 infected patients predict response to treatment". Journal of the International AIDS Society 21 8 (2018): https://publons.com/wos-op/publon/18444895/.
    Published
  74. Vos, Theo; Abajobir, Amanuel Alemu; Abate, Kalkidan Hassen; Abbafati, Cristiana; Abbas, Kaja M; Abd-Allah, Foad; Abdulkader, Rizwan Suliankatchi; et al. "Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016". The Lancet 390 10100 (2017): 1211-1259. http://dx.doi.org/10.1016/s0140-6736(17)32154-2.
    Open access • Published • 10.1016/s0140-6736(17)32154-2
  75. Naghavi, M.; Abajobir, A.A.; Abbafati, C.; Abbas, K.M.; Abd-Allah, F.; Abera, S.F.; Aboyans, V.; et al. "Global, regional, and national age-sex specifc mortality for 264 causes of death, 1980-2016: A systematic analysis for the Global Burden of Disease Study 2016". The Lancet 390 10100 (2017): 1151-1210. http://www.scopus.com/inward/record.url?eid=2-s2.0-85031727040&partnerID=MN8TOARS.
    Open access • Published • 10.1016/S0140-6736(17)32152-9
  76. Martin, F.; Palladino, C.; Mateus, R.; Bolzan, A.; Gomes, P.; Brito, J.; Carvalho, A.P.; et al. "Early infant diagnosis of HIV-1 infection in Luanda, Angola, using a new DNA PCR assay and dried blood spots". PLoS ONE 12 7 (2017): http://www.scopus.com/inward/record.url?eid=2-s2.0-85024842860&partnerID=MN8TOARS.
    Open access • Published • 10.1371/journal.pone.0181352
  77. Wang, H.; Abajobir, A.A.; Abate, K.H.; Abbafati, C.; Abbas, K.M.; Abd-Allah, F.; Abera, S.F.; et al. "Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970-2016: A systematic analysis for the Global Burden of Disease Study 2016". The Lancet 390 10100 (2017): 1084-1150. http://www.scopus.com/inward/record.url?eid=2-s2.0-85031719180&partnerID=MN8TOARS.
    Open access • Published • 10.1016/S0140-6736(17)31833-0
  78. Hay, S.I.; Abajobir, A.A.; Abate, K.H.; Abbafati, C.; Abbas, K.M.; Abd-Allah, F.; Abdulle, A.M.; et al. "Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2016: A systematic analysis for the Global Burden of Disease Study 2016". The Lancet 390 10100 (2017): 1260-1344. http://www.scopus.com/inward/record.url?eid=2-s2.0-85031764078&partnerID=MN8TOARS.
    10.1016/S0140-6736(17)32130-X
  79. Rocha, C.; Duarte, J.; Borrego, P.; Calado, R.; Marcelino, J.M.; Tendeiro, R.; Valadas, E.; et al. "Potency of HIV-2-specific antibodies increase in direct association with loss of memory B cells". AIDS 31 17 (2017): 2431-2433. http://www.scopus.com/inward/record.url?eid=2-s2.0-85034061405&partnerID=MN8TOARS.
    Published • 10.1097/QAD.0000000000001661
  80. Barber, R.M.; Fullman, N.; Sorensen, R.J.D.; Bollyky, T.; McKee, M.; Nolte, E.; Abajobir, A.A.; et al. "Healthcare access and quality index based on mortality from causes amenable to personal health care in 195 countries and territories, 1990-2015: A novel analysis from the global burden of disease study 2015". The Lancet 390 10091 (2017): 231-266. http://www.scopus.com/inward/record.url?eid=2-s2.0-85019850160&partnerID=MN8TOARS.
    Open access • Published • 10.1016/S0140-6736(17)30818-8
  81. Vos, T.; Abajobir, A.A.; Abbafati, C.; Abbas, K.M.; Abate, K.H.; Abd-Allah, F.; Abdulle, A.M.; et al. "Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: A systematic analysis for the Global Burden of Disease Study 2016". The Lancet 390 10100 (2017): 1211-1259. http://www.scopus.com/inward/record.url?eid=2-s2.0-85031738724&partnerID=MN8TOARS.
    10.1016/S0140-6736(17)32154-2
  82. Borrego, P.; Gonçalves, M.F.; Gomes, P.; Araújo, L.; Moranguinho, I.; Brito Figueiredo, I.; Barahona, I.; et al. "Assessment of the cavidi exavir load assay for monitoring plasma viral load in HIV-2-infected patients". Journal of Clinical Microbiology 55 8 (2017): 2367-2379. http://www.scopus.com/inward/record.url?eid=2-s2.0-85026198131&partnerID=MN8TOARS.
    Published • 10.1128/JCM.00235-17
  83. Fullman, N.; Barber, R.M.; Abajobir, A.A.; Abate, K.H.; Abbafati, C.; Abbas, K.M.; Abd-Allah, F.; et al. "Measuring progress and projecting attainment on the basis of past trends of the health-related Sustainable Development Goals in 188 countries: An analysis from the Global Burden of Disease Study 2016". The Lancet 390 10100 (2017): 1423-1459. http://www.scopus.com/inward/record.url?eid=2-s2.0-85029166308&partnerID=MN8TOARS.
    Open access • Published • 10.1016/S0140-6736(17)32336-X
  84. Kraemer, M.U.G.; Faria, N.R.; Reiner, R.C.; Golding, N.; Nikolay, B.; Stasse, S.; Johansson, M.A.; et al. "Spread of yellow fever virus outbreak in Angola and the Democratic Republic of the Congo 2015–16: a modelling study". The Lancet Infectious Diseases 17 3 (2017): 330-338. http://www.scopus.com/inward/record.url?eid=2-s2.0-85010723210&partnerID=MN8TOARS.
    Published • 10.1016/S1473-3099(16)30513-8
  85. Perdigão, João; Clemente, Sofia; Ramos, Jorge; Masakidi, Pedro; Machado, Diana; Silva, Carla; Couto, Isabel; et al. "Genetic diversity, transmission dynamics and drug resistance of Mycobacterium tuberculosis in Angola". Scientific Reports 7 (2017): S38-S39. http://hdl.handle.net/10362/24634.
    https://doi.org/10.1038/srep42814
  86. Romero-Severson, Ethan O; Bulla, Ingo; Hengartner, Nick; Bártolo, Inês; Abecasis, Ana; Azevedo-Pereira, José M; Taveira, Nuno; et al. "Donor-Recipient Identification in Para- and Poly-phyletic Trees Under Alternative HIV-1 Transmission Hypotheses Using Approximate Bayesian Computation". Genetics 207 3 (2017): 1089-1101. http://hdl.handle.net/10362/36493.
    Published • https://doi.org/10.1534/genetics.117.300284
  87. Xiong, Shengwen; Borrego, Pedro; Ding, Xiaohui; Zhu, Yuanmei; Martins, Andreia; Chong, Huihui; Taveira, Nuno; et al. "A Helical Short-Peptide Fusion Inhibitor with Highly Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus.". Journal of Virology 91 1 (2017): https://publons.com/wos-op/publon/15908009/.
    Published • 10.1128/JVI.01839-16
  88. Patrícia A. Serra; Andreia Martins; Taveira, Nuno; Guedes, Rita C. 741F-74C9-93AE. "Computational Approach to Structural and conformational characterization of Viral Surface Glycoproteins of HIV-2". Proceedings 1 6 (2017): 228. https://doi.org/10.3390/proceedings1060228.
    Open access • Published • 10.3390/proceedings1060228
  89. Cunha-Santos, C.; Figueira, T.N.; Borrego, P.; Oliveira, S.S.; Rocha, C.; Couto, A.; Cantante, C.; et al. "Development of synthetic light-chain antibodies as novel and potent HIV fusion inhibitors". AIDS 30 11 (2016): 1691-1701. http://www.scopus.com/inward/record.url?eid=2-s2.0-84964048560&partnerID=MN8TOARS.
    10.1097/QAD.0000000000001108
  90. Chen, C.-Y.; Shingai, M.; Welbourn, S.; Martin, M.A.; Borrego, P.; Taveira, N.; Strebel, K.; et al. "Antagonism of BST-2/tetherin is a conserved function of the Env glycoprotein of primary HIV-2 isolates". Journal of Virology 90 24 (2016): 11062-11074. http://www.scopus.com/inward/record.url?eid=2-s2.0-85001093586&partnerID=MN8TOARS.
    10.1128/JVI.01451-16
  91. Döring, M.; Borrego, P.; Büch, J.; Martins, A.; Friedrich, G.; Camacho, R.J.; Eberle, J.; et al. "A genotypic method for determining HIV-2 coreceptor usage enables epidemiological studies and clinical decision support". Retrovirology 13 1 (2016): http://www.scopus.com/inward/record.url?eid=2-s2.0-85006761506&partnerID=MN8TOARS.
    10.1186/s12977-016-0320-7
  92. Pineda-Peña, A.-C.; Varanda, J.; Sousa, J.D.; Theys, K.; Bártolo, I.; Leitner, T.; Taveira, N.; et al. "On the contribution of Angola to the initial spread of HIV-1". Infection, Genetics and Evolution 46 (2016): 219-222. http://www.scopus.com/inward/record.url?eid=2-s2.0-84996590196&partnerID=MN8TOARS.
    10.1016/j.meegid.2016.08.009
  93. Bártolo, I.; Calado, R.; Borrego, P.; Leitner, T.; Taveira, N.; Bártolo, Inês; Calado, Rita; et al. "Rare HIV-1 subtype J genomes and a new H/U/CRF02-AG recombinant genome suggests an ancient origin of HIV-1 in Angola". AIDS Research and Human Retroviruses 32 8 (2016): 822-828. http://www.scopus.com/inward/record.url?eid=2-s2.0-84979977763&partnerID=MN8TOARS.
    10.1089/aid.2016.0084
  94. Doering, Matthias; Borrego, Pedro; Buech, Joachim; Martins, Andreia; Friedrich, Georg; Camacho, Ricardo Jorge; Eberle, Josef; et al. "Geno2pheno (coreceptor-hiv2): a new diagnostic tool for the genotypic determination of HIV-2 coreceptor usage". Journal of the International AIDS Society (2016): https://publons.com/wos-op/publon/10164558/.
  95. Martin, Francisco; Palladino, Claudia; Mateus, Rita; Clemente, Sofia; Gomes, PerpeTua; Taveira, Nuno. "Evaluation of an In-house Molecular HIV-1 Test to Assess Mother-to-Child HIV-1 Transmission in Angola (the APEHC Cohort)". JAIDS Journal of Acquired Immune Deficiency Syndromes (2016): https://publons.com/wos-op/publon/40211725/.
    10.1097/01.QAI.0000479713.77468.97
  96. Briz, V.; Sepúlveda-Crespo, D.; Diniz, A.R.; Borrego, P.; Rodes, B.; De La Mata, F.J.; Gómez, R.; et al. "Development of water-soluble polyanionic carbosilane dendrimers as novel and highly potent topical anti-HIV-2 microbicides". Nanoscale 7 35 (2015): 14669-14683. http://www.scopus.com/inward/record.url?eid=2-s2.0-84940416810&partnerID=MN8TOARS.
    10.1039/c5nr03644e
  97. Diniz, Ana Rita; Canhões, Raquel; Taveira, Nuno. "Profilaxia de pré-exposição da infeção por VIH". (2015): http://hdl.handle.net/10400.26/15084.
  98. Figueira, T. N.; Cunha Santos, A. C.; Borrego, P.; Fontes, C.; Taveira, N.; Aires da Silva, F.; Goncalves, J.; Castanho, M. A. R. B.; Veiga, A. S.. "Evaluating the protein-lipid interactions of F63, a broad and potent anti-HIV single domain antibody". European Biophysics Journal (2015): https://publons.com/wos-op/publon/10164540/.
  99. Diniz, Ana Rita; Canhões, Raquel; Taveira, Nuno. "PRE-EXPOSURE PROPHYLAXIS FOR PREVENTION OF HIV INFECTION". (2015): https://doi.org/10.25756/rpf.v7i2.3.
    https://doi.org/10.25756/rpf.v7i2.3
  100. Bártolo, I.; Zakovic, S.; Martin, F.; Palladino, C.; Carvalho, P.; Camacho, R.; Thamm, S.; et al. "HIV-1 diversity, transmission dynamics and primary drug resistance in Angola". PLoS ONE 9 12 (2014): http://www.scopus.com/inward/record.url?eid=2-s2.0-84916919875&partnerID=MN8TOARS.
    10.1371/journal.pone.0113626
  101. Palladino, C.; Briz, V.; Bellón, J.M.; Climent, F.J.; De Ory, S.J.; Mellado, M.J.; Navarro, M.L.; et al. "Determinants of highly active antiretroviral therapy duration in HIV-1-infected children and adolescents in Madrid, Spain, from 1996 to 2012". PLoS ONE 9 5 (2014): http://www.scopus.com/inward/record.url?eid=2-s2.0-84900338272&partnerID=MN8TOARS.
    10.1371/journal.pone.0096307
  102. Costa, F. A.; Miranda, I.; Cavaco Silva, P.; Fernandes, A. I.; Carneiro, C.; Taveira, N.. "Home medicines review in the elderly". International Journal of Clinical Pharmacy (2014): https://publons.com/wos-op/publon/9658069/.
  103. Palladino, C.; Briz, V.; Bellón, J.M.; Bártolo, I.; Carvalho, P.; Camacho, R.; Muñoz-Fernández, M.Á.; et al. "Predictors of attrition and immunological failure in HIV-1 patients on highly active antiretroviral therapy from different healthcare settings in mozambique". PLoS ONE 8 12 (2013): http://www.scopus.com/inward/record.url?eid=2-s2.0-84893370669&partnerID=MN8TOARS.
    10.1371/journal.pone.0082718
  104. Borrego, P.; Calado, R.; Marcelino, J.M.; Pereira, P.; Quintas, A.; Barroso, H.; Taveira, N.; et al. "An ancestral HIV-2/simian immunodeficiency virus peptide with potent HIV-1 and HIV-2 fusion inhibitor activity". AIDS 27 7 (2013): 1081-1090. http://www.scopus.com/inward/record.url?eid=2-s2.0-84879098341&partnerID=MN8TOARS.
    10.1097/QAD.0b013e32835edc1d
  105. Borrego, P.; Taveira, N.. "HIV-2 susceptibility to entry inhibitors". AIDS Reviews 15 1 (2013): 49-61. http://www.scopus.com/inward/record.url?eid=2-s2.0-84883072402&partnerID=MN8TOARS.
  106. Rocha, Cheila; Calado, Rita; Borrego, Pedro; Marcelino, José M.; Bártolo, Inês; Rosado, Lino; Cavaco-Silva, Patrícia; et al. "Evolution of the human immunodeficiency virus type 2 envelope in the first years of infection is associated with the dynamics of the neutralizing antibody response". Retrovirology 10 1 (2013): http://www.scopus.com/inward/record.url?scp=84885972003&partnerID=8YFLogxK.
    https://doi.org/10.1186/1742-4690-10-110
  107. "HIV-2 Susceptibility to Entry Inhibitors". AIDS Reviews (2013): https://publons.com/wos-op/publon/10164542/.
  108. Tendeiro, R.; Fernandes, S.; Foxall, R.B.; Marcelino, J.M.; Taveira, N.; Soares, R.S.; Baptista, A.P.; et al. "Memory B-cell depletion is a feature of HIV-2 infection even in the absence of detectable viremia". AIDS 26 13 (2012): 1607-1617. http://www.scopus.com/inward/record.url?eid=2-s2.0-84865461543&partnerID=MN8TOARS.
    10.1097/QAD.0b013e3283568849
  109. Borrego, P.; Calado, R.; Marcelino, J.M.; Bártolo, I.; Rocha, C.; Cavaco-Silva, P.; Doroana, M.; et al. "Baseline susceptibility of primary HIV-2 to entry inhibitors". Antiviral Therapy 17 3 (2012): 565-570. http://www.scopus.com/inward/record.url?eid=2-s2.0-84861694354&partnerID=MN8TOARS.
    10.3851/IMP1996
  110. Oliveira, V.; Bártolo, I.; Borrego, P.; Rocha, C.; Valadas, E.; Barreto, J.; Almeida, E.; Antunes, F.; Taveira, N.. "Genetic diversity and drug resistance profiles in HIV type 1- and HIV type 2-infected patients from Cape Verde Islands". AIDS Research and Human Retroviruses 28 5 (2012): 510-522. http://www.scopus.com/inward/record.url?eid=2-s2.0-84860482804&partnerID=MN8TOARS.
    10.1089/aid.2011.0174
  111. Faria, N.R.; Hodges-Mameletzis, I.; Silva, J.C.; Rodés, B.; Erasmus, S.; Paolucci, S.; Ruelle, J.; et al. "Phylogeographical footprint of colonial history in the global dispersal of human immunodeficiency virus type 2 group A". Journal of General Virology 93 4 (2012): 889-899. http://www.scopus.com/inward/record.url?eid=2-s2.0-84863289869&partnerID=MN8TOARS.
    10.1099/vir.0.038638-0
  112. Marcelino, J.M.; Borrego, P.; Nilsson, C.; Família, C.; Barroso, H.; Maltez, F.; Doroana, M.; et al. "Resistance to antibody neutralization in HIV-2 infection occurs in late stage disease and is associated with X4 tropism". AIDS 26 18 (2012): 2275-2284. http://www.scopus.com/inward/record.url?eid=2-s2.0-84870192423&partnerID=MN8TOARS.
    10.1097/QAD.0b013e328359a89d
  113. Borrego, Pedro; Calado, Rita; Marcelino, José M; Bártolo, Inês; Rocha, Cheila; Cavaco-Silva, Patrícia; Doroana, Manuela; et al. "Baseline susceptibility of primary HIV-2 to entry inhibitors". (2012): http://hdl.handle.net/10400.26/4993.
    10.3851/IMP1996
  114. Bartolo, IneS; Taveira, Nuno. "HIV-1 Diversity and Its Implications in Diagnosis, Transmission, Disease Progression, and Antiretroviral Therapy". Genetic Diversity in Microorganisms (2012): https://publons.com/wos-op/publon/43041220/.
    10.5772/34131
  115. Bártolo, I.; Abecasis, A.B.; Borrego, P.; Barroso, H.; McCutchan, F.; Gomes, P.; Camacho, R.; et al. "Origin and epidemiological history of HIV-1 CRF14_BG". PLoS ONE 6 9 (2011): http://www.scopus.com/inward/record.url?eid=2-s2.0-80053252119&partnerID=MN8TOARS.
    10.1371/journal.pone.0024130
  116. Santos, Â.; Clemente, S.; Bártolo, I.; Palladino, C.; Cavaco-Silva, P.; Franco, V.; Epalanga, M.; Pinto, R.; Taveira, N.. "Evaluation of the diagnostic performance of the rapid test VIKIA HIV1/2 in a highly complex HIV-1 epidemic". Diagnostic Microbiology and Infectious Disease 71 1 (2011): 90-92. http://www.scopus.com/inward/record.url?eid=2-s2.0-80051663920&partnerID=MN8TOARS.
    10.1016/j.diagmicrobio.2011.06.002
  117. Barroso, H.; Borrego, P.; Bártolo, I.; Marcelino, J.M.; Família, C.; Quintas, A.; Taveira, N.; et al. "Evolutionary and structural features of the C2, V3 and C3 envelope regions underlying the differences in HIV-1 and HIV-2 biology and infection". PLoS ONE 6 1 (2011): http://www.scopus.com/inward/record.url?eid=2-s2.0-79251624890&partnerID=MN8TOARS.
    10.1371/journal.pone.0014548
  118. Marcelino, J.M.; Borrego, P.; Rocha, C.; Barroso, H.; Quintas, A.; Novo, C.; Taveira, N.. "Potent and broadly reactive HIV-2 neutralizing antibodies elicited by a vaccinia virus vector prime-C2V3C3 polypeptide boost immunization strategy". Journal of Virology 84 23 (2010): 12429-12436. http://www.scopus.com/inward/record.url?eid=2-s2.0-78049524372&partnerID=MN8TOARS.
    10.1128/JVI.01102-10
  119. Skar, H.; Borrego, P.; Wallstrom, T.C.; Mild, M.; Marcelino, J.M.; Barroso, H.; Taveira, N.; Leitner, T.; Albert, J.. "HIV-2 genetic evolution in patients with advanced disease is faster than that in matched HIV-1 patients". Journal of Virology 84 14 (2010): 7412-7415. http://www.scopus.com/inward/record.url?eid=2-s2.0-77953755556&partnerID=MN8TOARS.
    10.1128/JVI.02548-09
  120. Andrade, Helena Rebelo de; Pereira, Cristiana; Gíria, Marta; Prudêncio, Ema; Brito, Maria João; Calé, Etelvina; Taveira, Nuno; et al. "Outbreak of acute respiratory infection among infants in Lisbon, Portugal, caused by human adenovirus serotype 3 and a new 7/3 recombinant strain". Journal of Clinical Microbiology 48 4 (2010): 1391-1396. http://hdl.handle.net/10400.18/208.
    doi:10.1128/JCM.02019-09
  121. Marcelino, J. M.; Borrego, P.; Nilsson, C.; Barroso, H.; Doroana, M.; Antunes, F.; Novo, C.; Taveira, N.. "Escape from neutralization is a frequent event in HIV-2 infection and is strongly associated with X4 tropism". AIDS Research and Human Retroviruses (2010): https://publons.com/wos-op/publon/10164530/.
  122. Bártolo, I.; Camacho, R.; Barroso, H.; Bezerra, V.; Taveira, N.; Bartolo, Ines; Camacho, Ricardo; et al. "Rapid clinical progression to AIDS and death in a persistently seronegative HIV-1 infected heterosexual young man". AIDS 23 17 (2009): 2359-2362. http://www.scopus.com/inward/record.url?eid=2-s2.0-70449344717&partnerID=MN8TOARS.
    10.1097/QAD.0b013e328332d5e1
  123. Bártolo, I.; Rocha, C.; Bartolomeu, J.; Gama, A.; Marcelino, R.; Fonseca, M.; Mendes, A.; et al. "Highly divergent subtypes and new recombinant forms prevail in the HIV/AIDS epidemic in Angola: New insights into the origins of the AIDS pandemic". Infection, Genetics and Evolution 9 4 (2009): 672-682. http://www.scopus.com/inward/record.url?eid=2-s2.0-68949103933&partnerID=MN8TOARS.
    10.1016/j.meegid.2008.05.003
  124. Bártolo, I.; Casanovas, J.; Bastos, R.; Rocha, C.; Abecasis, A.B.; Folgosa, E.; Mondlane, J.; et al. "HIV-1 genetic diversity and transmitted drug resistance in health care settings in Maputo, Mozambique". Journal of Acquired Immune Deficiency Syndromes 51 3 (2009): 323-331. http://www.scopus.com/inward/record.url?eid=2-s2.0-67651031262&partnerID=MN8TOARS.
    10.1097/QAI.0b013e3181a24906
  125. Bartolo, Ines; Rocha, Cheila; Bartolomeu, Jose; Gama, Antonio; Fonseca, Marlene; Mendes, Ana; Cristina, Filipa; et al. "Antiretroviral Drug Resistance Surveillance among Treatment-Naive Human Immunodeficiency Virus Type 1-Infected Individuals in Angola". Antimicrobial Agents and Chemotherapy 53 7 (2009): 3156-3158. http://hdl.handle.net/10451/21662.
    http://dx.doi.org/10.1128/AAC.00110-09
  126. Marcelino, J.M.; Nilsson, C.; Barroso, H.; Gomes, P.; Borrego, P.; Maltez, F.; Rosado, L.; et al. "Envelope-specific antibody response in HIV-2 infection: C2V3C3-specific IgG response is associated with disease progression". AIDS 22 17 (2008): 2257-2265. http://www.scopus.com/inward/record.url?eid=2-s2.0-56549116048&partnerID=MN8TOARS.
    10.1097/QAD.0b013e3283155546
  127. Borrego, P.; Marcelino, J.M.; Rocha, C.; Doroana, M.; Antunes, F.; Maltez, F.; Gomes, P.; et al. "The role of the humoral immune response in the molecular evolution of the envelope C2, V3 and C3 regions in chronically HIV-2 infected patients". Retrovirology 5 (2008): http://www.scopus.com/inward/record.url?eid=2-s2.0-53549101005&partnerID=MN8TOARS.
    10.1186/1742-4690-5-78
  128. Marcelino, Jose Maria; Nilsson, Charlotta; Barroso, Helena; Gomes, Perpetua; Borrego, Pedro; Maltez, Fernando; Rosado, Lino; et al. "Envelope-specific antibody response in HIV-2 infection". (2008): http://hdl.handle.net/10451/21640.
    http://dx.doi.org/10.1097/QAD.0b013e3283155546
  129. Lemey, Philippe; Kosakovsky Pond, Sergei L.; Drummond, Alexei J.; Pybus, Oliver G.; Shapiro, Beth; Barroso, Helena; Taveira, Nuno; et al. "Synonymous substitution rates predict HIV disease progression as a result of underlying replication dynamics". PLoS Computational Biology 3 2 (2007): 0282-0292. http://hdl.handle.net/10451/21395.
    http://dx.doi.org/10.1371/journal.pcbi.0030029
  130. Marcelino, J.M.; Barroso, H.; Gonçalves, F.; Silva, S.M.; Novo, C.; Gomes, P.; Camacho, R.; Taveira, N.. "Use of a new dual-antigen enzyme-linked immunosorbent assay to detect and characterize the human antibody response to the human immunodeficiency virus type 2 envelope gp125 and gp36 glycoproteins". Journal of Clinical Microbiology 44 2 (2006): 607-611. http://www.scopus.com/inward/record.url?eid=2-s2.0-32344453650&partnerID=MN8TOARS.
    10.1128/JCM.44.2.607-611.2006
  131. Bártolo, I.; Epalanga, M.; Bartolomeu, J.; Fonseca, M.; Mendes, A.; Gama, A.; Taveira, N.. "High genetic diversity of human immunodeficiency virus type 1 in Angola". AIDS Research and Human Retroviruses 21 4 (2005): 306-310. http://www.scopus.com/inward/record.url?eid=2-s2.0-18244396096&partnerID=MN8TOARS.
    10.1089/aid.2005.21.306
  132. Barroso, H.; Taveira, N.. "Evidence for negative selective pressure in HIV-2 evolution in vivo". Infection, Genetics and Evolution 5 3 SPEC. IS (2005): 239-246. http://www.scopus.com/inward/record.url?eid=2-s2.0-14544306887&partnerID=MN8TOARS.
    10.1016/j.meegid.2004.07.008
  133. Barroso, H.; Araújo, F.; Gomes, M.H.; Mota-Miranda, A.; Taveira, N.. "Phylogenetic demonstration of two cases of perinatal human immunodeficiency virus type 2 infection diagnosed in adulthood". AIDS Research and Human Retroviruses 20 12 (2004): 1373-1376. http://www.scopus.com/inward/record.url?eid=2-s2.0-11244308212&partnerID=MN8TOARS.
    10.1089/aid.2004.20.1373
  134. Cardoso, A.R.; Gonçalves, C.; Pascoalinho, D.; Gil, C.; Ferreira, A.F.; Bártolo, I.; Taveira, N.. "Seronegative infection and AIDS caused by an A2 subsubtype HIV-1". AIDS 18 7 (2004): 1071-1074. http://www.scopus.com/inward/record.url?eid=2-s2.0-2342567887&partnerID=MN8TOARS.
    10.1097/00002030-200404300-00018
  135. Faikensammer, B; Doerler, M; Kessler, HH; Puchammer-Stoeckl, E; Parson, W; Taveira, N; Barosso, H; Dierich, MP; Stoiber, H. "Phylogenetic and genotypic resistance analysis of HIV-1 infected patients in Austria". Journal of Molecular Diagnostics (2004): https://publons.com/wos-op/publon/10164536/.
  136. Azevedo-Pereira, J.M.; Santos-Costa, Q.; Taveira, N.; Veríssimo, F.; Moniz-Pereira, J.. "Construction and characterization of CD4-independent infectious recombinant HIV-2 molecular clones". Virus Research 97 2 (2003): 159-163. http://www.scopus.com/inward/record.url?eid=2-s2.0-0242266539&partnerID=MN8TOARS.
    10.1016/j.virusres.2003.08.008
  137. Antunes, R.; Figueiredo, S.; Bártolo, I.; Pinheiro, M.; Rosado, L.; Soares, I.; Lourenço, H.; Taveira, N.. "Evaluation of the clinical sensitivities of three viral load assays with plasma samples from a pediatric population predominantly infected with human immunodeficiency virus type 1 subtype G and BG recombinant forms". Journal of Clinical Microbiology 41 7 (2003): 3361-3367. http://www.scopus.com/inward/record.url?eid=2-s2.0-0037829662&partnerID=MN8TOARS.
    10.1128/JCM.41.7.3361-3367.2003
  138. Lizeng, Q.; Skott, P.; Sourial, S.; Nilsson, C.; Andersson, S.; Ehnlund, M.; Taveira, N.; et al. "Serum immunoglobulin A (IgA)-mediated immunity in human immunodeficiency virus type 2 (HIV-2) infection". Virology 308 2 (2003): 225-232. http://www.scopus.com/inward/record.url?eid=2-s2.0-0037431316&partnerID=MN8TOARS.
    10.1016/S0042-6822(02)00088-0
  139. Cardoso, Ana Rita; Gonçalves, Cristina; Pascoalinho, Dulce; Gil, Carla; Fernandes Ferreira, António; Bártolo, Inês; Taveira, Nuno. "A clinical case of seronegative AIDS". (2003): https://revista.spmi.pt/index.php/rpmi/article/view/1816.
  140. Mota-Miranda, A.; Gomes, H.; Lima-Alves, C.; Araújo, F.; Cuncha-Ribeiro, L.; Taveira, N.. "Perinatally acquired HIV-2 infection diagnosed at 15 and 24 years of age [2]". AIDS 15 18 (2001): 2460-2461. http://www.scopus.com/inward/record.url?eid=2-s2.0-0035824724&partnerID=MN8TOARS.
    10.1097/00002030-200112070-00018
  141. Marcelino, J.M.; Novo, C.; Picotez, F.; Clemente, A.; Pereira, J.M.; Taveira, N.. "Production and characterization of a mouse monoclonal antibody against the Gag p26 protein of human immunodeficiency virus type 2: Identification of a new antigenic epitope". AIDS Research and Human Retroviruses 17 13 (2001): 1279-1283. http://www.scopus.com/inward/record.url?eid=2-s2.0-0034803490&partnerID=MN8TOARS.
    10.1089/088922201750461348
  142. Gomes, P.; Taveira, N.C.; Moniz Pereira, J.; Antunes, F.; Santos Ferreira, M.O.; Lourenço, M.H.; Gomes, P; et al. "Quantitation of human immunodeficiency virus type 2 DNA in peripheral blood mononuclear cells by using a quantitative-competitive PCR assay". Journal of Clinical Microbiology 37 2 (1999): 453-456. http://www.scopus.com/inward/record.url?eid=2-s2.0-0345683492&partnerID=MN8TOARS.
    10.1128/JCM.37.2.453-456.1999
  143. Cavaco-Silva, P.; Taveira, N.C.; Rosado, L.; Lourenço, M.H.; Moniz-Pereira, J.; Douglas, N.W.; Daniels, R.S.; Santos-Ferreira, M.O.. "Virological and molecular demonstration of human immunodeficiency virus type 2 vertical transmission". Journal of Virology 72 4 (1998): 3418-3422. http://www.scopus.com/inward/record.url?eid=2-s2.0-0031925291&partnerID=MN8TOARS.
  144. MATHERON, S; COURPOTIN, C; SIMON, F; DIMARIA, H; BALLOUL, H; BARTZACK, S; DORMONT, D; et al. "VERTICAL TRANSMISSION OF HIV-2". The Lancet 349 9046 (1997): 177-178. https://publons.com/wos-op/publon/8149777/.
    10.1016/0140-6736(90)92682-8
  145. Taveira, N.C.; Santos Ferreira, M.O.; Moniz Pereira, J.. "Amplification of full-length HIV-2 envelope genes". Molecular and Cellular Probes 10 2 (1996): 91-98. http://www.scopus.com/inward/record.url?eid=2-s2.0-0343371797&partnerID=MN8TOARS.
    10.1006/mcpr.1996.0013
  146. Taveira, N.C.; Gomes, P.C.; Ferreira, M.O.S.; Pereira, J.M.. "Detection of hiv-1 dna by polymerase chain reaction incorporation of digoxigenin-11-dutp and hybridization to immobilized probes". Molecular and Cellular Probes 8 3 (1994): 235-240. http://www.scopus.com/inward/record.url?eid=2-s2.0-0028094953&partnerID=MN8TOARS.
    10.1006/mcpr.1994.1033
  147. Taveira, N.C.; Bex, F.; Burny, A.; Sharp, P.M.; Ferreira, M.O.S.; Moniz-Pereira, J.. "Erratum: Molecular characterization of the env gene from a non-syncytium- inducing HIV-2 isolate (HIV-2(ALI)) (Aids Research and Human Retroviruses (1994) 10:2 (223-224))". AIDS Research and Human Retroviruses 10 4 (1994): 431-431. http://www.scopus.com/inward/record.url?eid=2-s2.0-0028218094&partnerID=MN8TOARS.
  148. TAVEIRA, NC; BEX, F; BURNY, A; SHARP, PM; FERREIRA, MOS; MONIZPEREIRA, J; Taveira, N.C.; et al. "MOLECULAR CHARACTERIZATION OF THE ENV GENE FROM A NON-SYNCYTIUM-INDUCING HIV-2 ISOLATE (HIV-2(ALI)) (VOL 10, PG 223, 1994)". AIDS Research and Human Retroviruses 10 2 (1994): 223-224. https://publons.com/wos-op/publon/10164531/.
    10.1089/aid.1994.10.223
  149. Taveira, N.C.; Ferreira, M.O.S.; Pereira, J.M.. "Detection of HIV1 proviral DNA by PCR and hybridization with digoxigenin labelled probes". Molecular and Cellular Probes 6 4 (1992): 265-270. http://www.scopus.com/inward/record.url?eid=2-s2.0-0026905746&partnerID=MN8TOARS.
    10.1016/0890-8508(92)90001-E
Online resource
  1. Döring, Matthias; Büch, Joachim; Friedrich, Georg; Lengauer, Thomas; Pfeifer, Nico; Thielen, Alexander; Borrego, Pedro; Taveira, Nuno. geno2pheno[coreceptor-hiv2] - This is an algorithm to support clinical decision-making in the treatment of HIV-2 infection, by genotyping the use of CCR5 and CXCR4 coreceptors by HIV-2. The information generated makes it possible, among other applications, to assess the susceptibility of the virus to a class of antiviral drugs (HIV entry inhibitors) and, consequently, their clinical indication.. 2015. https://coreceptor-hiv2.geno2pheno.org/index.php.
Preprint
  1. Nuno Taveira; Paloma Gonçalves; Jorge Barreto; Menilita Santos; Silvania Leal; José Marcelino; Ana Abecasis; et al. "HIV-1 drug resistance and genetic diversity in people with HIV-1 in Cape Verde, 2019-2021". 2023. https://doi.org/10.22541/au.169631469.96124050/v1.
    10.22541/au.169631469.96124050/v1
Thesis / Dissertation
  1. Gaudino, Beatriz Carrilho. "O papel da porphyromonas gingivalis na etiologia das doenças sistémicas e orais". Master, 2022. http://hdl.handle.net/10400.26/42979.
  2. Martin, Francisco Neves Dos Santos. "HIV infection in Angola : Molecular epidemiology, diagnosis and antibody neutralization". PhD, 2022. http://hdl.handle.net/10451/54919.
  3. Salgado, José Duarte Lopes. "Vacinas para vírus sincicial respiratório : o estado da arte". Master, 2021. http://hdl.handle.net/10400.26/38898.
  4. GONÇALVES, Paloma Catarina Barradas. "Análise genética e funcional dos genes pol e env e caracterização da resposta em anticorpos neutralizantes em adultos infetados por VIH-1 de Moçambique". Master, 2021. http://hdl.handle.net/10362/129347.
  5. Duarte, Inês Coimbra Batista. "Evolução do microbioma oral humano e o seu impacto na saúde oral". Master, 2021. http://hdl.handle.net/10400.26/38478.
  6. Silva, André Reis Catarino Neiva da. "Caracterização do microbioma peri-implantar e da peri-implantite : revisão sistemática". Master, 2021. http://hdl.handle.net/10400.26/38232.
  7. Serra, Patrícia Filipa Alves. "Viral surface glycoproteins as potential drug targets against HIV-1 and HIV-2 infections". PhD, 2021. http://hdl.handle.net/10451/48510.
  8. Coelho, Rute Irina Costa Cavaco Kittler. "Impacto do microbioma intestinal na ação dos medicamentos". Master, 2020. http://hdl.handle.net/10400.26/35087.
  9. Saïz, Perrine Hélène Francine. "Influências dos probióticos na saúde oral". Master, 2019. http://hdl.handle.net/10400.26/29740.
  10. Pacheco, Laís Neves. "Etiologia e tratamento das infeções endodônticas". Master, 2019. http://hdl.handle.net/10400.26/30535.
  11. Bernardo, Miguel Filipe Moura. "Estudo piloto : caracterização in vivo do microbioma formado em superfícies mistas e totalmente maquinadas de implantes de titânio". Master, 2019. http://hdl.handle.net/10400.26/30885.
  12. Santos, António Joaquim Amorim. "Genoma mitocondrial: contributos para o estudo de marcadores genéticos com interesse médico-legal, forense e populacional em imigrantes oriundos de países africanos integrados na população de Lisboa". PhD, 2019. http://hdl.handle.net/10174/25596.
  13. Adeoye, Oluwatomide. "Cyclodextrin supramolecular systems for oral antiretroviral drug delivery". PhD, 2019. http://hdl.handle.net/10451/42258.
  14. Opanasiuk, Maksym. "Tratamento antibiótico da periodontite : o estado da arte". Master, 2019. http://hdl.handle.net/10400.26/30890.
  15. Martins, Andreia Rodrigues, 1983-. "Characterization of HIV-2 susceptibility to protease and entry inhibitors and identification of envelope determinants of coreceptor usage, cell tropism and antibody neutralization". PhD, 2018. http://hdl.handle.net/10451/32315.
  16. Costa, Ana Rita Ramos Diniz de Quadros e, 1988-. "New prevention and treatment strategies for HIV infection". PhD, 2018. http://hdl.handle.net/10451/34145.
  17. Gonçalves, Fabiana Sofia Castro; Gonçalves, João Miguel Alves. "Prevalência, incidência e impacto das doenças orais na qualidade de vida em Portugal e Grécia 2005/2016". Master, 2018. http://hdl.handle.net/10400.26/25190.
  18. Calado, Rita Diogo de Almeida, 1982-; Calado, Rita. "Development and pre-clinical evaluation of a new HIV-1 vaccine concept". PhD, 2018. http://hdl.handle.net/10451/32686.
  19. Correia, Mónica Graça. "Cura do HIV : barreiras e perspetivas futuras". Master, 2018. http://hdl.handle.net/10400.26/25607.
  20. Mendonça, Patrícia Valadas; Canhões, Raquel Salazar Albuquerque Rodrigues. "Profilaxia de pré-exposição na infeção por HIV-1". Master, 2017. http://hdl.handle.net/10400.26/20178.
  21. Mascote, Catarina Samuel. "Novas formas de caracterização do micobioma oral". Master, 2017. http://hdl.handle.net/10400.26/20211.
  22. Coelho, Nuno Bettencourt. "Implementation of linear network coding over a flexible emulator". Master, 2016. http://hdl.handle.net/10071/13019.
  23. Alegria, Beatriz Alves Costa. "Vírus de Marburg: epidemiologia, patogenecidade, diagnóstico laboratorial e terapêutica". Master, 2016. http://hdl.handle.net/10400.26/15323.
  24. Antão, Ana Isabel Vieira. "In vitro infection of lymphoid tissues by HIV-2". Master, 2016. http://hdl.handle.net/10451/28421.
  25. Lérias, Susana Maria Lopes. "Suscetibilidade genética às doenças orais de etiologia microbiana". Master, 2016. http://hdl.handle.net/10400.26/17479.
  26. Lemos, André Filipe Pereira de. "O papel da Porphyromonas gingivalis nas doenças da cavidade oral e sua relação com doenças sistémicas". Master, 2016. http://hdl.handle.net/10400.26/14659.
  27. Nunes, Eva Solange Cordeiro. "Doença causada pelo vírus Ébola: epidemiologia, patogénese, tratamento e prevenção". Master, 2016. http://hdl.handle.net/10400.26/17591.
  28. Carvalho, Teresa Campino de. "O viroma oral". Master, 2016. http://hdl.handle.net/10400.26/17463.
  29. Raposo, Raquel Alexandra Ribeiro. "Probióticos e doença periodontal". Master, 2016. http://hdl.handle.net/10400.26/14697.
  30. Teixeira, Catarina Gonçalves Pinto. "Microbioma endodôntico". Master, 2015. http://hdl.handle.net/10400.26/10882.
  31. Correia, Filipe André Saraiva. "Microbioma humano: implicações biomédicas". Master, 2015. http://hdl.handle.net/10400.26/10989.
  32. Raposo, Inês Dias de Sousa. "Diagnóstico de infeção por HIV em amostras de fluido oral". Master, 2015. http://hdl.handle.net/10400.26/11785.
  33. Castanho, Joana Cascais Palmeirim. "Diabetes mellitus e o micobioma oral". Master, 2015. http://hdl.handle.net/10400.26/11770.
  34. Fajardo, Anabela Cristina da Silva. "Caracterização do microbioma humano". Master, 2015. http://hdl.handle.net/10400.26/10975.
  35. Vitorino, João Tiago Lopes. "Doenças periodontais e sua relação com patologia sistémica e farmacoterapia associada". Master, 2015. http://hdl.handle.net/10400.26/11773.
  36. Esteves, Margarida Gonçalves. "Cura da infecção por HIV : conceitos e aplicações". Master, 2014. http://hdl.handle.net/10400.26/13070.
  37. Candeias, Patrícia Raquel da Silva. "O HIV-2 como modelo para uma vacina contra o HIV-1". Master, 2014. http://hdl.handle.net/10400.26/13080.
  38. Zakovic, Suzana. "Identification of HIV-1 transmission clusters: application in epidemiological studies and forensic cases". Master, 2013. http://hdl.handle.net/10400.26/19076.
  39. Castelão, Ana Isabel Freitas. "A epidemiologia da infeção por HIV-2". Master, 2013. http://hdl.handle.net/10400.26/14119.
  40. Rocha, Cheila Cristina Pereira Alves, 1978-. "Analysis of antibody neutralization specificities in human immunodeficiency virus type 2 infection". PhD, 2013. http://hdl.handle.net/10451/9188.
  41. Bártolo, Inês Isabel Fernandes, 1975-. "Molecular epidemiology and evolution of HIV-1 in Portugal and portuguese speaking african countries". PhD, 2011. http://hdl.handle.net/10451/4456.
  42. Marcelino, José Maria, 1959-. "Resposta humoral na infecção por VIH-2 : impacto no diagnóstico, prevenção e evolução viral". PhD, 2011. http://hdl.handle.net/10451/3795.
  43. Clemente, Sofia Vanda Lôa, 1970-. "Epidemiologia molecular da infecção por VIH/SIDA, em Angola". Master, 2008. http://hdl.handle.net/10451/3322.

Intellectual property

Patent
  1. Teresa M. V. D. Pinho e Melo; Santos, BS; Bártolo, Inês; Prudêncio, Miguel; Taveira, Nuno. 2023. "Novel Spiro-Lactams, Process and Uses Thereof.". United States.
    Granted/Issued
  2. Taveira, Nuno; Melo, Teresa M. V. D. Pinho e; Bártolo, I.; Miguel Prudêncio; Santos, B. 2023. "NOVEL SPIRO-LACTAM COMPOUNDS, PROCESS AND USES THEREOF". United States.
    Granted/Issued
  3. Taveira N; de Sousa Barroso M H; Marcelino J M. 2007. "COMPOSITIONS AND METHODS FOR DIAGNOSING HIV-2 INFECTION".
    Expired

Other

Other output
  1. Bacteriophage isolation from human saliva: a pilot study with high school students. Abstract in proceedings of the Fourth International Congress of CiiEM: Health, Well-Being and Ageing in the 21st Century, held at Egas Moniz’ University Campus in Monte de Caparica, Almada, from 3–5 June 2019.. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distrib. 2021. Nascimento, Teresa; Marvão, Matilde; Bugalho, Joana; Bastos, Marta; Luz, Andreia; Maurício, Paulo; Taveira, Nuno. http://hdl.handle.net/10400.26/40724.
    10.1080/07853890.2021.1896919
Activities

Supervision

Thesis Title
Role
Degree Subject (Type)
Institution / Organization
2022 - 2022 TECNOLOGIA DE EDIÇÃO GENÉTICA CRISPR/CAS NA PREVENÇÃO E TRATAMENTO DOS CARCINOMAS DA CABEÇA E DO PESCOÇO CAUSADOS POR HPV - REVISÃO SISTEMÁTICA
Supervisor
Medicina Dentária (Master)
Instituto Universitário Egas Moniz, Portugal
2022 - 2022 COMPARAÇÃO IN VITRO ENTRE QUATRO MÉTODOS DE DESCONTAMINAÇÃO EM IMPLANTES CONTAMINADOS COM PSEUDOMONAS AERUGINOSA
Supervisor
Medicina Dentária (Master)
Instituto Universitário Egas Moniz, Portugal
2022 - 2022 O PAPEL DA PORPHYROMONAS GINGIVALIS NA ETIOLOGIA DAS DOENÇAS SISTÉMICAS E ORAIS
Supervisor
Medicina Dentária (Master)
Instituto Universitário Egas Moniz, Portugal
2021 - 2021 Caracterização do microbioma peri-implantar e da peri-implantite: revisão sistemática
Supervisor
Medicina Dentária (Master)
Instituto Universitário Egas Moniz, Portugal
2021 - 2021 Evolução do microbioma oral humano e o seu impacto na saúde oral
Supervisor
Medicina Dentária (Master)
Instituto Universitário Egas Moniz, Portugal
2021 - 2021 "Análise genética e funcional dos genes pol e env e caracterização da resposta em anticorpos neutralizantes em adultos infetados por VIH-1 em Moçambique."
Supervisor
Ciências Biomédicas (Master)
Universidade Nova de Lisboa Instituto de Higiene e Medicina Tropical, Portugal
2021 - 2021 Vacinas para vírus respiratórios, o estado da arte
Supervisor
Ciências Farmacêuticas (Master)
Instituto Universitário Egas Moniz, Portugal
2021 - 2021 Treatment and Cure of HIV Infection: Available Drugs, Resistance Pathways, and Promising New Compounds
Supervisor
Farmácia (PhD)
Universidade de Lisboa Faculdade de Farmácia, Portugal
2020 - 2020 Impacto da microbioma intestinal na ação dos medicamentos
Supervisor
Ciências Farmacêuticas (Master)
Instituto Universitário Egas Moniz, Portugal
2020 - 2020 Prevalência, incidência e impacto das doenças orais na qualidade de vida em Portugal, Itália, Grécia e Espanha, 2005-2019
Supervisor
Medicina Dentária (Master)
Instituto Universitário Egas Moniz, Portugal
2019 - 2019 Influências dos probióticos na saúde oral
Supervisor
Medicina Dentária (Master)
Instituto Universitário Egas Moniz, Portugal
2019 - 2019 Etiologia e tratamento das infecções endodonticas
Supervisor
Medicina Dentária (Master)
Instituto Universitário Egas Moniz, Portugal
2019 - 2019 Tratamento antibiótico da periodontite: o estado da arte
Supervisor
Medicina Dentária (Master)
Instituto Universitário Egas Moniz, Portugal
2018 - 2018 Cura do HIV - barreiras e perspectivas futuras
Supervisor
Ciências Farmacêuticas (Master)
Instituto Universitário Egas Moniz, Portugal
2018 - 2018 Prevalência, incidência e impacto das doenças orais na qualidade de vida em Portugal e na Grécia 2005/2016
Supervisor
Medicina Dentária (Master)
Instituto Universitário Egas Moniz, Portugal
2017 - 2017 Characterization of HIV-2 susceptibility to protease and entry inhibitors and identification of envelope determinants of coreceptor usage, cell tropism and antibody neutralization
Supervisor
Farmácia (PhD)
Universidade de Lisboa Faculdade de Farmácia, Portugal
2017 - 2017 Profilaxia pré-exposição na infeção por HIV-1
Supervisor
Ciências Farmacêuticas (Master)
Instituto Universitário Egas Moniz, Portugal
2017 - 2017 Novas formas de caracterização do micobioma oral
Supervisor
Medicina Dentária (Master)
Instituto Universitário Egas Moniz, Portugal
2017 - 2017 Viral surface glycoproteins as potential drug targets against HIV-1 and HIV-2 infections
Co-supervisor
Farmácia (PhD)
Universidade de Lisboa Faculdade de Farmácia, Portugal
2016 - 2016 New prevention and treatment strategies for HIV infection
Supervisor
Farmácia (PhD)
Universidade de Lisboa Faculdade de Farmácia, Portugal
2016 - 2016 HIV infection in Angola: molecular epidemiology diagnosis and antibody neutralization
Supervisor
Farmácia (PhD)
Universidade de Lisboa Faculdade de Farmácia, Portugal
2016 - 2016 Genoma Mitocondrial: Contributo para o Estudo de Marcadores Genéticos com Interesse Médico-Legal, Forense e Populacional em Imigrantes Oriundos de Países Africanos Integrados na População de Lisboa.
Supervisor
Biologia (PhD)
Universidade de Évora Instituto de Investigação e Formação Avançada, Portugal
2016 - 2016 O papel da Porphyromonas Gingivalis nas doenças da cavidade oral e sua relação com doenças sistémicas
Supervisor
Medicina Dentária (Master)
Instituto Universitário Egas Moniz, Portugal
2016 - 2016 Probióticos e doença periodontal
Supervisor
Medicina Dentária (Master)
Instituto Universitário Egas Moniz, Portugal
2016 - 2016 Vírus de Marburg: epidemiologia, patogeneciade, diagnóstico laboratorial e terapêutica
Supervisor
Ciências Farmacêuticas (Master)
Instituto Universitário Egas Moniz, Portugal
2016 - 2016 Suscetibilidade genética às doenças orais de etiologia microbiana
Supervisor
Medicina Dentária (Master)
Instituto Universitário Egas Moniz, Portugal
2016 - 2016 Doença causada pelo Vírus Ébola: epidemiologia, patogénese, tratamento e prevenção
Supervisor
Ciências Farmacêuticas (Master)
Instituto Universitário Egas Moniz, Portugal
2015 - 2015 Microbioma Endodôntico
Supervisor
Medicina Dentária (Master)
Instituto Universitário Egas Moniz, Portugal
2015 - 2015 Caracterização do microbioma humano
Supervisor
Ciências Farmacêuticas (Master)
Instituto Universitário Egas Moniz, Portugal
2015 - 2015 Microbioma humano: implicações biomédicas
Supervisor
Ciências Farmacêuticas (Master)
Instituto Universitário Egas Moniz, Portugal
2015 - 2015 Diagnóstico de infeção por HIV em amostras de fluido oral
Supervisor
Medicina Dentária (Master)
Instituto Universitário Egas Moniz, Portugal
2015 - 2015 Diabetes mellitus e o micobioma oral
Supervisor
Medicina Dentária (Master)
Instituto Universitário Egas Moniz, Portugal
2015 - 2015 Doenças periodontais e sua relação com patologia sistémica e farmacoterapia associada
Supervisor
Medicina Dentária (Master)
Instituto Universitário Egas Moniz, Portugal
2014 - 2014 Cura da infecção por HIV: conceitos e aplicações
Supervisor
Ciências Farmacêuticas (Master)
Instituto Universitário Egas Moniz, Portugal
2014 - 2014 O HIV-2 como modelo para uma vacina contra o HIV-1
Supervisor
Ciências Farmacêuticas (Master)
Instituto Universitário Egas Moniz, Portugal
2013 - 2013 A epidemiologia da infeção por HIV-2
Supervisor
Ciências Farmacêuticas (Master)
Instituto Universitário Egas Moniz, Portugal
2013 - 2013 Profilaxia de pré-exposição da infeção por HIV
Supervisor
Ciências Farmacêuticas (Master)
Instituto Universitário Egas Moniz, Portugal
2012 - 2012 Development and pre-clinical evaluation of a new HIV-1 vaccine concept
Supervisor
Farmácia (PhD)
Universidade de Lisboa Faculdade de Farmácia, Portugal
2009 - 2009 Analysis of Antibody Neutralization Specificities in Hiv2 Infection Human Imunodeficiency Virus
Supervisor
Farmácia (PhD)
Universidade de Lisboa Faculdade de Farmácia, Portugal
2008 - 2008 Molecular Epidemiology and Evolution of Hiv1 in Portugal and Portuguese Speaking African Countries
Supervisor
Farmácia (PhD)
Universidade de Lisboa, Portugal
2008 - 2008 Probing entry inhibitors activity on HIV and development of new fusion inhibitors: integrating evolutionary biology with virology.
Supervisor
Farmácia (PhD)
Universidade de Lisboa, Portugal
2005 - 2005 Evolução Genética, Antigenicidade e Imunogenicidade do Invólucro do Vih-2
Supervisor
Farmácia (PhD)
Universidade de Lisboa, Portugal
2003 - 2003 Resposta humoral na infecção VIH-2: Impacto no diagnóstico, prevenção e evolução viral.
Supervisor
Ciências Biomédicas (PhD)
Universidade de Lisboa, Portugal

Consulting

Activity description Institution / Organization
2021/12/10 - 2022/01/31 Assessment of the possible impact of Hop latent viroid (HLVd), Cannabis cryptic virus (CCV) and Lettuce mosaic virus (LMV) present in Cannabis sativa L., on Human Health. Clever Leaves Portugal Unipessoal Lda, Portugal

Evaluation committee

Activity description
Role
Institution / Organization Funding entity
2023/04/03 - 2024/01/14 Review of a project submitted to Medical Research Council Peer Review (UKRI MRC ). APP15512: Pre-clinical in vivo development of thapsigargin (TG) as a broad-spectrum respiratory antiviral.
Evaluator
UK Research and Innovation, United Kingdom UK Centre for Medical Research and Innovation
2021 - 2022 Reviewer of project applications for Portugal2020, AAC 25/SI/2016 or 26/SI/2016, National Agency for Inovation (Agência Nacional de Inovação), Portugal.
Evaluator
Agência Nacional de Inovação SA, Portugal Agência para o Investimento e Comércio Externo de Portugal EPE
Distinctions

Award

2022 R2 Value 2022 Edition Course Pitch session
Universidade Nova de Lisboa Faculdade de Ciências e Tecnologia, Portugal
2021 First prize in the Health category of the Born From knowledge ideas (Bfk) competition of the National Innovation Agency (ANI) with the project Spiro4malaids (https://www.f6s.com/spiro4malaids).
Agência Nacional de Inovação SA, Portugal
2019 Janssen Real World Evidence Data Award 2019 (third prize), Portugal.
2016 Genese Program, Gilead Sciences, Portugal
2016 National Agency for Innovation (Agência Nacional de Inovação, ANI), Portugal, to fund a patent submission
2015 Barretina Prize “O Colégio Militar no Mundo” (Military College in the World).
2014 Janssen Virology Award 2014 (2nd Prize), Portugal
2013 Janssen Virology Award 2013 (2nd prize)
2013 Health Awards IX- Personality of the Year
Egas Moniz Cooperativa de Ensino Superior CRL, Portugal
2012 Pfizer Award in Clinical Research
2011 Janssen Virology award 2010 (first prize)
2003 José Luís Champalimaud Prize
1997 José Luis Champalimaud Prize

Other distinction

2020 Best poster award in Medicinal Chemistry, Encontro Nacional de Química Orgânica e Terapêutica, Aveiro, Portugal
2008 Best oral presentation, 11ª Anual Meeting of the Associação Portuguesa para o Estudo do Fígado
2004 Best poster award, 5º Congresso Nacional sobre SIDA, Portugal
1999 Best Poster Award, 7th European Conference on Clinical Aspects and Treatment of HIV-1 infection, 1999, Lisbon, Portugal.